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ABSTRACT
Recent evidence indicates that U.S.-born infants are larger today
compared to 20 years ago. A strong determinant of neonatal size is maternal
body mass, where larger mothers deliver larger infants. Consistent evidence
indicates that higher levels of maternal physical activity (PA) during pregnancy
reduce the risk of delivering a larger infant. However, this protective effect has
only been demonstrated in normal weight pregnant women. Little is known about
the relationship between maternal PA and neonatal size in overweight or obese
pregnant women. Moreover, no studies have examined the association between
maternal cardiorespiratory fitness (CRF), an indicator of habitual PA, on infant
size in this pregnant subpopulation. Thus, the overall purpose of this dissertation
was to determine if maternal PA moderates the association between maternal
body mass and infant size and whether maternal PA and/or CRF are associated
with neonatal size in overweight or obese pregnant women.
In study one, logistic regression analyses were performed to evaluate the
moderating roles of maternal PA in the preconception and prenatal periods on
the association between maternal body mass index (BMI) and the risk of
delivering a macrosomic infant. Maternal BMI and physical activity served as the
main predictor variables. Regression models were adjusted for maternal age and
race/ethnicity, gestational age and weight gain, smoking and alcohol use, and
infant sex. Overweight or obese pregnant women had increased odds of
v

delivering a macrosomic infant (OR = 1.69, p <0.0001; OR = 1.67, p=0.003).
Neither maternal PA in the preconception nor prenatal periods modified the
association between maternal BMI and the risk of delivering a macrosomic
neonate (OR=0.98, p=0.34; OR=1.00, p=0.13, respectively), after adjusting for
covariates. The present study does not support the hypothesis that maternal PA
prior to or during pregnancy alters the relationship between maternal BMI and
infant size.
In study two, multiple linear regression models were constructed to
determine the independent and joint associations of maternal PA and CRF with
infant birthweight. Maternal PA and CRF were the main predictors and
regression models were adjusted for gestational age, maternal age and weight
gain, and group allocation. After adjusting for covariates, multiple linear
regression analyses showed that maternal PA (steps day-1 month-1) (β= 0.03 g,
95% CI: -0.03, 0.08g) and CRF (ml O2·kg-1·min-1) (β= -8.83 g, 95%CI: -42.2, 24.5 g)
were not independently nor jointly (β= 0.006 g, 95%CI: -0.005, 0.005 g)
associated with offspring birthweight. Contrary to hypotheses, maternal PA and
CRF during pregnancy were not related to infant birthweight in overweight or
obese pregnant women.
In study three, individual trajectories for maternal PA in the prenatal period
were estimated via repeated measures analyses to represent the change in PA
from mid (4th month) to late (8th month) pregnancy. Multiple linear regression
models were then performed to determine the association between change in
prenatal PA and birthweight. Change in maternal PA was the main predictor and
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regression models were adjusted for gestational age, weight gain, maternal age
and group allocation. PA declined from the 4th to the 8th month of pregnancy (399.73 ± 371.38 steps∙day-1∙month-1). After adjusting for covariates, multiple
linear regression analyses showed that the decline in prenatal PA (β= -0.28 g,
95%CI: -0.70, 0.25 g, p=0.35) was not associated with birthweight. In addition,
CRF (β= 0.04 g, 95%CI: -0.06 g, 0.14 g, p=0.697) did not exhibit a moderating
effect. Maternal physical activity declined in mid-to-late pregnancy, and contrary
to hypotheses, the observed decrement was found to be unrelated to infant
birthweight.
Overall, the findings from these studies demonstrate that higher levels of
maternal physical activity prior to and during pregnancy do not modify the
relationship between maternal body mass and neonatal size. In addition, these
findings indicate that maternal physical activity and cardiorespiratory fitness do
not independently or jointly associate with neonatal birthweight. These studies
provide information about these relationships in an understudied subpopulation
and contribute to this rapidly growing area of research. Several
recommendations are suggested to address the limitations of these studies
including sampling strategies that will increase variability in PA and CRF levels,
more rigorous and precise measures of PA and infant anthropometry and the
inclusion of metabolic biomarker assessments.
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INTRODUCTION
Compelling evidence indicates that higher levels of physical activity (PA)
and cardiorespiratory fitness (CRF) are associated with numerous health
benefits(4). These positive health outcomes are documented across various
subpopulations(8, 21). Specifically, young adult women who participate in
sufficient amounts of PA and develop healthy levels of CRF exhibit lower levels
of body fat(19), and improved metabolic(10) and reproductive health(9).
Moreover, research shows that pregnant women benefit from optimal levels of
PA and CRF (17), with prenatal PA leading to increased perceptions of energy,
and reduced feelings of fatigue(11), improved mood(16), and positive effects on
gestational weight gain(13) and postpartum weight retention(14). Based on
scientific evidence, women are encouraged to accumulate at least 150 minutes
of moderate PA per week throughout the duration of their pregnancy(18, 20).
While there are many well-documented maternal health benefits related to higher
levels of PA in the prenatal period, much less is known about the effects of PA on
the neonate.
Infant birthweight is a strong indicator of fetal development and wellbeing(24). Neonates born at either end of the birthweight distribution have
increased risks of several morbidities and mortality(1, 2). While the birth of small
and large neonates and their associated health outcomes are of equal public
health importance, recent evidence indicates that over the past 20 years the
1

average birthweight of U.S.-born infants has increased(12). Consequently, these
higher birthweights may lead to altered growth trajectories(25), and predispose
neonates to overweight or obesity and the related adverse cardio-metabolic
outcomes in childhood and adolescence(7). Importantly, a strong determinant of
neonatal weight is maternal body mass index. That is, larger mothers tend to
deliver larger infants(22). This is evidenced by the high rate of larger neonates
among overweight or obese women(5). Considering the increasing prevalence of
high body mass index among women of reproductive age(6), evaluating factors
that may reduce the risk of the development of a larger neonate, especially in the
overweight or obese population, is important to the long-term health of the infant.
Consistent evidence demonstrates that higher levels of maternal PA in
pregnancy protects the fetus from overgrowth, thus promoting the delivery of a
healthy-sized neonate(23). Unfortunately, the protective effect of maternal PA is
only demonstrated among normal weight women. As such, little is known about
the effects of maternal PA during pregnancy in overweight or obese pregnant
women. Moreover, in normal weight and overweight or obese pregnant women,
the effects of CRF, an indicator of habitual PA, on neonatal weight is unclear as
studies assessing this relationship are inconsistent(3, 15) and non-existent in
these subpopulations, respectively. Thus, the purpose of this dissertation project
was to evaluate how maternal PA and CRF influence maternal adiposity and
infant size during the prenatal period. This dissertation included three separate
studies. The first study analyzed data from the National Maternal Infant Health
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Survey of 1988 (NMIHS). The second and third study drew data from a previous
randomized controlled exercise intervention trial(26, 27).
The aim of the first study was to determine if maternal PA in the
preconception and prenatal periods modifies the association between maternal
and infant weight status in a nationally representative sample of mothers
delivering live-birth infants in 1988. Importantly, only one study to date has
evaluated this relationship, however this study only considered the impact of
maternal PA in the preconception period, failing to account for the potential
influence of PA in the prenatal period. The aim of this study was to independently
assess the moderating effects of maternal PA in both the preconception and
prenatal periods on the association between maternal adiposity (i.e. body mass
index) and infant size (i.e. birthweight, size for gestational age).
The second study determined the independent and joint associations
between maternal PA and CRF and infant birthweight in a sample of overweight
or obese pregnant women. Many studies evaluated the relationship between
maternal PA in pregnancy and infant size. However, very few studies were
conducted among overweight or obese women. Currently, no studies examined
the relationship between maternal CRF and infant birthweight in this group. The
aim of this study was addressed with three objectives. The first two objectives
separately assessed the independent associations between maternal PA and
CRF and infant birthweight. The third objective evaluated the joint association of
maternal PA and CRF and infant birthweight.
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The third study determined the influence of the change in maternal PA and
CRF in the prenatal period and infant birthweight in a sample of overweight or
obese women. Existing prospective studies evaluating the relationship between
maternal physical activity and infant size primarily focused on the effects of the
average level of physical activity across pregnancy or during specific trimesters
on birthweight. Consequently, these studies failed to account for the naturally
occurring changes in maternal physical activity. As such, the impacts of the
changes in maternal physical activity across the prenatal period on infant size are
largely unknown. The aim of this study was addressed with two objectives. The
first objective examines the association between the change in maternal PA from
mid-to-late pregnancy on infant birthweight. The second objective evaluated the
potential moderating effect of maternal CRF on the association between change
in maternal PA and infant birthweight.
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CHAPTER 1
MODERATING EFFECTS OF MATERNAL PHYSICAL ACTIVITY PRIOR TO
AND DURING PREGNANCY ON THE RELATIONSHIP BETWEN MATERNAL
ADIPOSITY AND INFANT MACROSOMIA

9

Abstract
Purpose: Compelling evidence demonstrates that maternal pre-pregnancy body
mass index is a significant determinant of infant size. Given the strong metabolic
effects of physical activity (PA), it is unclear as to whether PA in the prenatal
period may modify the association between maternal body mass and infant size.
Therefore, the purpose of this study was to evaluate the modifying effect of
maternal PA in the preconception and prenatal periods.
Methods: Data were from National Maternal and Infant Health Survey conducted
in 1988. Women with singleton pregnancies, delivering term (37 to 44 weeks),
live-birth infants (n=6,390). Macrosomia was defined as a birthweight greater
than 4,000g. Maternal PA in the preconception and prenatal periods were selfreported by the mother. Multiple logistic regression models were performed to
determine the moderating effects of maternal PA in the preconception and
prenatal periods. Analyses were adjusted for maternal age, race/ethnicity,
gestational age and weight gain, smoking and alcohol use, and infant sex.
Results: Mothers were on average 25 years of age and nearly 25% were
overweight or obese. In the prenatal period, these women gained approximately
14 kg (30lbs) and delivered full-term (39.6 ± 1.6 weeks), live-birth infants
weighing nearly 3300g (3.3kg; 7lbs 4 oz.). Maternal body mass was a significant,
positive predictor of infant macrosomia (OR = 1.06, p <0.0001). After adjusting
for covariates, neither maternal PA in the preconception (OR=0.98, p=0.34) nor
prenatal (OR=1.00, p=0.13) periods were associated with offspring birthweight.
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Conclusions: Maternal body mass was a significant, positive predictor of infant
macrosomia. However, higher levels of maternal PA prior to and/or during
pregnancy were unrelated to infant macrosomia or birthweight in a nationally
representative sample of women delivering singleton, term infants. The use of
more precise measurements of maternal PA and neonatal size are strongly
recommended.
Introduction
The prevalence of infant macrosomia, defined as a birthweight greater
than 4,000 g, has increased in US and other developed countries. (4, 14).
Macrosomic infants are predisposed to altered growth trajectories and increased
risk of obesity and the associated co-morbidities later in life(8, 24). Maternal body
mass is a significant predictor of macrosomia (23), where larger mothers tend to
deliver larger infants. The relationship between maternal body mass and infant
macrosomia is thought to be a function of the mother’s overall metabolic health,
which is a strong determinant of the amount of energy reaching the fetus. Thus,
because mothers with greater body mass often have poorer metabolic
health(11), their fetuses are often exposed to excess energy resulting in the
development of a larger infant (9, 16).
Considerable scientific evidence demonstrates that participation in
sufficient levels of physical activity (PA) exerts strong effects on metabolic health.
Given that maternal metabolic health underlies the relationship between maternal
body mass and infant birthweight, higher levels of maternal PA prior to and/or
during pregnancy may be necessary to prevent the development of an overgrown
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infant, especially in larger mothers. This hypothesis is supported by the rigorous
evidence demonstrating the effects of PA on several non-communicable
diseases (NCDs) including non-alcoholic fatty liver and cardiovascular diseases,
in non-pregnant populations(6, 15). Individuals participating in higher levels of PA
exhibited reduced risks of several NCDs and specifically, metabolic diseases
such as type II diabetes mellitus, regardless of weight status(7). As such, it is
reasonable to suggest that the beneficial effects of PA on metabolic health found
in non-pregnant populations, may exist in the preconception and/or prenatal
periods. If so, mothers engaging in higher levels of PA prior to and/or during
pregnancy may have improved metabolic health, controlling energy supply to
their fetuses, and subsequently less likely to deliver a macrosomic infant,
regardless of their body mass.
Evidence regarding maternal PA as a potential modifier of the relationship
between maternal body mass and infant macrosomia is limited (13). To our
knowledge only one study has evaluated this relationship and found that, for
overweight or obese pregnant women, physical inactivity before pregnancy
increased the risk of delivering a macrosomic infant compared to active women.
A limitation of that study was that the authors did not evaluate PA in the prenatal
period. It is possible that higher levels of maternal PA in the preconception andor prenatal periods may affect infant macrosomia. As such, determining the
influence of maternal PA prior to and during pregnancy on infant macrosomia is
important, and these findings may better inform PA guidelines for pregnant and
future pregnant women. To our knowledge, no studies have evaluated the
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potential moderating effects of maternal PA in the preconception and prenatal
periods on infant size. Therefore, the purpose of this study is to determine if
maternal PA in both the preconception and prenatal periods moderate the
association between maternal body mass index and the risk of delivering a
macrosomic infant.
Methods
Study Design & Sampling
Data for the present study were from The National Maternal Infant Health
Survey (NMIHS). The NMIHS was conducted by the National Center for Health
Statistics in 1988 in order to identify factors that may be related to poor
pregnancy outcomes(18). The NMIHS employed a follow-back survey design and
sampled U.S. women who had a live birth, fetal death or infant death in 1988. To
make inferences on a nationally representative sample, the NMIHS used a
complex survey design that drew stratified samples of live-births, fetal and infant
deaths identified via registered birth and death certificates. Black, very low
(<1500g)- and moderately low- birthweight (2500-2499g) infants were
oversampled. For the purposes of this study, only singleton, live-birth infants and
their mothers were included in the analyses.
Study Population & Data Collection
A total of 13,417 live-birth infants were sampled. To identify factors related
to poor pregnancy outcomes, mothers of these infants were mailed a 35-page
questionnaire that inquired about several maternal, paternal and infant
characteristics during the preconception, prenatal and postnatal periods. The
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average recall period, defined as the time between delivery of the infant and the
receipt of the questionnaire, was 17 months. Of the 13, 417 mothers, 74.2%
(n=9954) responded to the questionnaire. Some differences in the characteristics
of mothers whom responded and did not respond to the questionnaire were
observed. Mothers between the ages of 20 to 39 years, who were White,
married, had fewer than four children, received early prenatal care, achieved
more education, and resided in the Midwest region of the U.S. were more likely
to respond to the questionnaire. Mothers of low-birthweight (<2500g) infants were
less likely to respond to the questionnaire.
Outcome Variable: Infant Macrosomia
Infant macrosomia was the primary outcome variable in this study.
Macrosomia was defined as a birthweight greater than 4,000g. Birthweight was
defined as the weight of the infant, in grams, at the time of delivery. Birthweight
and gestational age data were extracted from birth certificates. Birthweights less
than 300 grams or greater than 9000 grams were considered implausible(19) and
excluded from the analyses.
Exposure Variables
Maternal Body Mass Index
Maternal pre-pregnancy body mass index (BMI) was calculated using the
standard equation:

=

ℎ

÷ℎ

ℎ

. Maternal pre-pregnancy

height and weight were self-reported by the mother. In all analyses, maternal BMI
was treated as a continuous variable.
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Maternal Physical Activity
Maternal PA in the preconception and prenatal periods were examined as
potential moderating variables in this study. Pre-pregnancy PA was measured
using the following question: “Did you exercise or play sports at least three times
a week before you got pregnant...include brisk walking for ½ hour or more,
jogging, aerobic swimming etc.?” The response was recorded as “yes” or “no.”
Prenatal PA was assessed using two separate questions. First, mothers were
asked the following question: “Did you exercise or play sports at least three times
a week after you got pregnant…include brisk walking for ½ hour or more,
jogging, aerobic swimming etc.?” the response was recorded as “yes” or “no.”
Mothers answering ‘yes’ to this question answered the second PA question:
“How many months of this pregnancy did you engage in exercise or play sports
at least three times a week?” In this study, for mothers answering ‘no’ to
participation in PA in the prenatal period, a value of 0 was entered for the second
prenatal PA question.
Covariate Variables: Maternal and Infant
Several maternal and infant characteristics were considered as potential
covariates. Data were extracted from the mothers’ questionnaire and infant birth
certificate. Maternal demographic characteristics that were considered potential
covariates were: age (in years), and race/ethnicity (Non-Hispanic White, NonHispanic Black, Hispanic and Other). Maternal pregnancy-related factors
included as possible covariates were: gestational weight gain (GWG) and parity.
GWG was calculated as the difference in weight (in pounds) at the time of
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delivery and prior to pregnancy. Maternal behaviors that were considered
potential covariates included: smoking status and alcohol use. For these
behaviors, the mothers self-reported the use of cigarettes or consumption of
alcohol in the last 12 months prior to delivery. Infant characteristics that acted as
possible covariates included: sex (male or female) and gestational age (weeks).
For live-birth infants, gestational ages less than 22 weeks or greater than 44
weeks were considered implausible(19).
Analytic Sample
Of the 9,953 mothers, 9,146 women had singleton pregnancies. Of these
women, 2,052 women delivered pre-term infants (22 to 36 weeks), and 6,390
women delivered a live-birth infant between 37 and 44 weeks gestation (i.e. fullterm). In addition, of the women with singleton pregnancies (n=9,146), 264
women had implausible values for either gestational age (n=248) or infant
birthweight (n=16), 455 women had missing data for either gestational age
(n=448) or birthweight (n=7). The final sample size for this study was 6,390
women. Differences in several maternal and infant demographics and behavioral
characteristics between the analytic and excluded samples are presented in
Table 1.
Statistical Analyses
To determine if maternal pre-pregnancy and-or prenatal PA moderate the
association between maternal BMI and infant macrosomia, we performed
multiple logistic regression analyses. First, we examined the unadjusted main
effects of maternal BMI on infant macrosomia. Second, we separately assessed
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the unadjusted main effects of pre-pregnancy PA and prenatal PA in conjunction
with maternal BMI on infant macrosomia. Third, to determine the unadjusted
moderating effects of pre-pregnancy PA and prenatal PA, we entered an
interaction term between pre-pregnancy PA and maternal BMI and an interaction
between prenatal PA and maternal BMI, in separate models. Lastly, we entered
the maternal and infant covariates sequentially.
Because the NMIHS employed a complex survey design to make
inferences on a nationally representative sample, weights were generated to
account for non-response and study design and were included in all statistical
analyses. All statistical analyses were performed in SAS statistical software
version 9.4 (Cary, North Carolina). For the multiple logistic regression, with infant
macrosomia as the outcome variable, odds ratios were estimated. For the
multiple linear regression analyses, with infant birthweight (in grams) as the
outcome variable mean regression coefficients were estimated. An alpha level of
0.05 was used to denote statistical significance for all analyses.
Results
The sample characteristics for the women included and excluded in the
present analyses are documented in Table 1.1. Because the analysis was
restricted to singleton, full-term pregnancies, differences in gestational age,
maternal weight gain, maternal body mass index, and infant size were expected.
No other meaningful significant differences were found.
For the analytic sample, mothers were, on average, 25 years of age and
nearly 25% were overweight or obese. In the prenatal period, these women
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gained approximately 14 kg (30lbs) and delivered full-term (39.6 ± 1.6 weeks),
live-birth infants weighing nearly 3300g (3.3kg; 7lbs 4 oz.). The prevalence of
infant macrosomia (9.3%) was slightly above the current U.S. prevalence
estimate (8%) (14). Roughly 30% and 40% of mothers reported smoking and/or
alcohol use in the 12 months prior to the birth of their child, respectively. In the
preconception period, nearly 50% of mothers reported being active at least three
times per week for at least 30 minutes. Forty-two percent of mothers reported
being active at least three times per week for at least 30 minutes in the prenatal
period. These mothers maintained this dose of PA for nearly three months (2.8 ±
3.8 months) of their pregnancy.
Preliminary analyses showed that maternal BMI was a significant positive
predictor of infant size. Specifically, overweight or obese mothers had increased
odds of delivering a macrosomic infant compared to normal weight mothers (OR
= 1.69, p <0.0001; OR = 1.67, p=0.0032, respectively). For the unadjusted
moderating effect of maternal PA in the preconception period, our analyses
revealed that participation in PA prior to pregnancy did not exhibit a moderating
effect on the association between maternal BMI and the odds of delivering a
macrosomic infant (OR = 0.97, p=0.16). Similarly, after adjusting for prenatal PA,
gestational age and weight gain, maternal age and race/ethnicity, smoking and
alcohol use, and infant sex, the moderating effect of maternal PA in the
preconception period remained non-significant (OR=0.98, p=0.34) [see Table
1.2].
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The unadjusted analysis for the moderating effect of maternal PA in the
prenatal period showed that participation in PA during pregnancy significantly
modified the association between maternal BMI and the odds of delivering a
macrosomic infant (OR = 0.995, p=0.04). However, after controlling for
preconception PA, gestational age and weight gain, maternal age and
race/ethnicity, smoking and alcohol use, and infant sex, the moderating effect of
PA in the prenatal period was no longer statistically significant (OR=1.00, p=0.13)
[see Table 1.3].
Additional analyses were performed, using multiple linear regression, to
evaluate the moderating effect of maternal PA prior to and during pregnancy on
maternal BMI and infant birthweight. Similar to the logistic regression analyses,
maternal BMI was a significant, positive predictor of infant birthweight (β = 14.55
± 1.70 g, p<0.0001). Moreover, maternal engagement in PA prior to pregnancy
did not modify the relationship between maternal BMI and neonatal birthweight in
the unadjusted or adjusted regression models (β = -2.42 ± 3.38 g, p=0.47; β= 1.12 ± 3.26, p=0.73, respectively). Correspondingly, maternal PA during
pregnancy did not significantly modify the association between maternal BMI and
infant birthweight in the unadjusted or adjusted regression models (β= -0.82 ±
0.46 g, p=0.08; β= -0.51 ± 0.45 g, p=0.26, respectively).
Discussion
The purpose of this study was to evaluate the moderating effect of
maternal physical activity in both the preconception and prenatal periods on the
relationship between maternal body mass and infant macrosomia. Consistent
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with previous literature, our study found that maternal body mass was positively
associated with the delivery of a macrosomic infant. However, there was no
modifying effect of maternal PA in the preconception period on the association
between maternal body mass and infant macrosomia. Similarly, in the prenatal
period, maternal PA was not found to exert a modifying effect on this relationship.
This present study was unique in that it was the first to evaluate the potential
modifying effects of maternal PA both prior to and during pregnancy. Only one
other study, to our knowledge, has evaluated this relationship, however that
examination was restricted to the preconception period(13). Thus, this present
study provides important information about the relationships between maternal
PA and body mass and neonatal size.
Our observation that maternal PA in the preconception period does not
modify the association between maternal body mass and infant macrosomia
conflicts with the current literature. Only one other study has evaluated this
relationship and these authors found that in overweight or obese women, low
levels of maternal PA prior to pregnancy increased the risk of delivering a
macrosomic neonate(13). The inconsistent findings between these studies may
be consequent to non-differential misclassification as result of the measurement
tool used to assess maternal PA. Both studies used a self-reported method to
evaluate maternal prior to pregnancy, however, questions inquiring used varied
greatly. In the Krogsgaard et al. (2013) study, women were asked to report the
frequency, intensity and duration of the physical activities in which they
participated in the preconception period. In the present study, women were
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asked about their participation in a specific dose of PA (i.e. three times/week for
30 minutes). The specificity of the PA dose in this question may have led women
to be inappropriately categorized as ‘active’ or ‘inactive.’ For example, if a woman
participated in PA twice per week for 60 minutes, an equivalent dose of PA, she
would have been classified as ‘inactive’ given she did not meet the three-day per
week requirement. Consequently, this misclassification may have diluted the
potential modifying effect of maternal PA, explaining our null observation(22).
Thus, more open-ended questions or objective measurements of PA may provide
information that more accurately reflects maternal PA behavior prior to
pregnancy.
In the present study, maternal PA in the prenatal period exhibited no
moderating effect on the relationship between maternal body mass and neonatal
size. A possible explanation for this null observation is that the dose of PA these
women engaged in was insufficient to impact maternal metabolic health and
subsequently infant birthweight. In this study, women were considered ‘active’ if
they participated in PA three times per week for at least 30 minutes. This amount
of PA is less than the dose recommended by the United States Department of
Health and Human Services and endorsed by the American Congress of
Obstetricians and Gynecologists(20, 21). These entities encourage pregnant
women to engage in at least 150 minutes of activity per week. In addition, it is
likely that these women participated in less PA throughout the prenatal period as
it is well-documented that maternal PA declines in pregnancy(10, 17). In support
of this idea, women responding ‘yes’ to being physically active in pregnancy were
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subsequently asked to report the number of months they maintained this
behavior. On average, these women participated in this dose of PA for only three
months of their pregnancy. This suggests that their PA declined, mostly likely in
the final two trimesters, however we are unable to quantify the extent to which it
decreased. Consequently, the lower dose and potential decline of maternal PA
likely resulted in these women participating in levels of PA that were insufficient
to impact maternal metabolic health, fetal nutrient supply and subsequently fetal
growth and neonatal size. Currently, in the existing literature a dose of PA that is
sufficient to regulate fetal nutrient supply and ultimately reduce the risk of infant
macrosomia, has yet to be identified.
Another potential explanation for the null observation of maternal PA in the
prenatal period as a modifier is non-differential misclassification of maternal PA
behavior. The question evaluating maternal PA in the prenatal period was similar
to the question assessing PA in the preconception period, as such, it suffers from
the same limitations. The specificity of the dose of PA may have resulted in
women being inappropriately classified as ‘active’ or ‘inactive.’ In addition to this,
the extensive recall period may have also contributed to the misclassification.
The average recall period, defined as the amount of time that lapsed between the
delivery of the neonate and the receipt of the maternal questionnaire, was 17
months. As such, the ability of the mother to accurately recall her PA behavior
during her pregnancy (or before pregnancy) may have been significantly
diminished. Evidence demonstrates that there is an inverse relationship between
length of the recall period and the ability of an individual to accurately recall their
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behavior(2). Due to these considerable limitations of the measurement tool used
to assess maternal PA, it is possible that our null observation is attributed to nondifferential misclassification. As a result, the potential modifying effect of maternal
PA in the prenatal period on the relationship between maternal body mass and
infant size was possibly diluted(22).
This study has strengths and limitations. Foremost, this was the first study
to evaluate maternal PA in the preconception and prenatal periods as a modifier
of the relationship between maternal body mass and neonatal size. Second, this
study was conducted using a large, diverse, nationally representative sample of
women delivering singleton, full-term, live-birth infants in the United States. As
such, our findings can be generalized to a large sample of women. However, the
present study also has limitations. First, maternal PA and body mass were
measured via self-reporting methods. This type of assessment is notorious for
producing less accurate estimates of behavior compared to more objective
assessments(1, 5). Consequently, the use of these imprecise and error-prone
tools may have led to biased, misestimated associations(3). Second, we did not
consider other potential health behaviors that have been documented to
influence infant size, including maternal diet (26). Third, although infant
birthweight is the most widely used metric for infant size, it has limitations. This
metric is unable to capture vital details about infant size including tissue
composition (i.e. fat and fat-free mass) that are key to future health risks of these
neonates(8). Lastly, macrosomia is poorly defined in the current literature. The
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birthweight thresholds that define macrosomia vary greatly (i.e. > 4000, > 45000,
> 5000g) (12, 25). As such, it is possible that we misclassified classified infants.
In conclusion, the present study observed that maternal PA in the
preconception and prenatal periods did not exhibit a modifying effect on the
relationship between maternal body mass and infant size. This was the first study
to evaluate this relationship and thus, provides important information about these
relationships and contributes to the rapidly growing field of maternal-child health.
Future studies should address the limitations of the present study. First, more
precise assessments of maternal PA behavior and maternal and infant
anthropometrics are necessary. Second, future researchers should include the
assessment of metabolic biomarkers, such as serum glucose and lipids. These
factors are posited to be the mechanisms that underlie these relationships,
however are often ignored in studies. In conclusion, the findings of this study
provide no evidence that higher levels of maternal PA in the preconception or
prenatal periods modify the association between maternal body mass and
neonatal size.
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Table 1.1 Maternal and infant sample characteristics
Sample Characteristics
Maternal a
Age (y)**
Race/Ethnicity (%)***
NH White
NH Black
Hispanic
Other.
Body Mass Index (kg/m2)***
Underweight (%)
Normal Weight (%)
Overweight (%)
Obese (%)
Prenatal Behaviors
Smoking†***
Drinking†
Preconception PA†**
Prenatal PA†**
Prenatal PA*** (# of months)
Infant***
Gestational age
Gestational weight gain
Birthweight (g)
Macrosomia (%)
Sex (%)
Male

Analytic
Group
N
Mean

SD

6393
6393
2745
2868
566
214
6393

25.8

5.7

42.9
44.9
8.9
3.4
23.1

623
4181
489
1100

Excluded
Group
N
Mean

SD

25.4

6.0

----------------4.6

3388
3388
1151
1842
307
88
3388

34.0
54.4
9.1
2.6
23.0

----------------4.9

9.8
65.4
17.2
7.7

-----------------

435
2110
546
297

12.8
62.3
16.1
8.8

6393
6393
6393
6393
6393

28.4
38.7
48.5
42.4
2.8

----------------3.6

3388
3388
3388
3380
3388

33.2
37.8
45.6
36.9
2.1

----------------3.0

6393
6393
6390
6393

39.6
13.9
3293.5
9.31

1.6
8.1
595.6
-----

2877
3388
3384
3388

31.8
11.1
1974.2
1.6

5.1
9.3
999.6
-----

6393

51.0

-----

3388

50.2

-----

Note: *p<0.05; **p<0.01 ***p<0.0001. The analytic sample was defined as
women delivering full-term (37 to 44 weeks), live-birth infants in 1988. The
excluded sample was defined as women delivering non-full-term infants (<37
weeks), or those with implausible gestational ages for live-births (<22 or >44
weeks). †’No’ is the referent group. These values correspond to the raw data
from the women sampled in the NMIHS survey, sample weights were not applied
to account for the complex survey design.
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Table 1.2. Adjusted multiple logistic regression coefficientsa for the moderating
effect of maternal physical activity in the preconception period on the
relationship between maternal body mass index and the odds of delivering a
macrosomic infant (>4,000g).
Parameter Estimates
Predictors

β

SE

OR

p-value

Primary Exposures
BMI (kg/m2)†
Preconception PA§
BMI * Preconception PA§

0.09
0.39
-0.02

0.01
0.50
0.02

1.09
1.48
0.980

<0.0001
0.44
0.34

-0.001

0.02

0.98

0.95

0.21
0.05
-0.76
0.07
0.58
0.03

0.03
0.01
0.13
0.11
0.11
0.01

1.24
1.06
0.47
1.08
1.78
1.03

<0.0001
<0.0001
<0.0001
0.5101
<0.0001
0.0013

-0.88
-1.30
-0.27

0.11
0.39
0.18

0.41
0.27
0.77

<0.0001
0.0009
0.13

Covariates
Prenatal PA (no. of
months)
Gestational Age (weeks)
Gestational weight gain
Smoking*
Drinking*
Infant Sex**
Maternal Age
Maternal Race/Ethnicity***
NH Black
Other
Hispanic
a

Referent group for the outcome variable = average-for-gestational age (AGA).

Only regression coefficients for large-for-gestational age are displayed. OR =
odds ratio. †BMI is calculated from pre-pregnancy weight and height selfreported by the mother. § ‘No’ is the referent group. * ‘No’ is the referent group.
** ‘Female’ is the referent group. ***NH = Non-Hispanic, NH White is the referent
group. Sample weights were applied to account for non-response and study
design.
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Table 1.3. Adjusted multiple logistic regression coefficientsa for the moderating
effect of maternal physical activity in the prenatal period (no. of months) on the
relationship between maternal body mass index and the odds of delivering a
macrosomic infant (>4,000g).
Parameter Estimates
Predictors

β

SE

OR

p-value

Primary Exposures
BMI (kg/m2)†
Prenatal PA
BMI * Prenatal PA

0.09
0.10
-0.004

0.01
0.07
0.003

1.10
1.11
1.00

<0.0001
0.13
0.13

-0.08
0.21

0.13
0.03

0.93
1.24

0.55
<0.0001

0.05
-0.76
0.07
0.58
0.03

0.01
0.13
0.11
0.11
0.01

1.06
0.47
1.07
1.78
1.03

<0.0001
<0.0001
0.52
<0.0001
0.0010

-0.89
-1.30
-0.27

0.11
0.39
0.18

0.41
0.27
0.77

<0.0001
0.0010
0.13

Covariates
Preconception PA§
Gestational Age
(weeks)
Gestational weight gain
Smoking*
Drinking*
Infant Sex**
Maternal Age
Maternal
Race/Ethnicity***
NH Black
Other
Hispanic
a

Referent group for the outcome variable = average-for-gestational age (AGA).

Only regression coefficients for large-for-gestational age are displayed. OR =
odds ratio. †BMI is calculated from pre-pregnancy weight and height selfreported by the mother. § ‘No’ is the referent group. * ‘No’ is the referent group.
** ‘Female’ is the referent group. ***NH = Non-Hispanic, NH White is the referent
group. Sample weights were applied to account for non-response and study
design.
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CHAPTER 2
ASSOCIATIONS BETWEEN MATERNAL PHYSICAL ACTIVITY AND
CARDIORESPIRATORY FITNESS DURING PREGNANCY AND INFANT
BIRTHWEIGHT
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Abstract
Purpose: Significant evidence demonstrates that physical activity (PA) during
pregnancy reduces the risk of delivering heavier infants. However, this
relationship is restricted to normal-weight pregnant women. In addition, the
evidence on the impact of maternal cardiorespiratory fitness (CRF), an objective
indicator of habitual PA, on offspring birthweight is equivocal. Therefore, the
purpose of this study was to evaluate the relationship between maternal PA and
CRF during pregnancy and offspring birthweight in a sample of overweight or
obese pregnant women.
Methods: This study employed a prospective design using data from a
randomized controlled exercise intervention trial in sedentary, overweight or
obese pregnant women with a history of preeclampsia. Women with complete
data (n=89) on infant birthweight, peak oxygen consumption (at 17 weeks), and
daily PA measured via a pedometer (17 weeks to delivery) were eligible for
analyses. Multiple linear regression models were performed to determine the
independent and joint associations of PA and CRF with offspring birthweight.
Gestational age, weight gain, and group allocation were considered as
covariates.
Results: On average, participants were 32 years old, overweight/obese (BMI
29.97 ± 7.14 kg/m2), unfit (VO2peak: 19.85 ± 3.35 ml O2·kg-1·min-1), and led low active
lifestyles (6,579.91 ± 2379.17 steps/day). After adjusting for covariates, multiple
linear regression analyses showed that maternal PA (steps day-1 month-1) (β=
0.03 g, 95% CI: -0.03, 0.08g) and CRF (ml O2·kg-1·min-1) (β= -8.8 g, 95%CI: -42.2,
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24.5 g) were not independently nor jointly (β= 0.006g, 95%CI: -0.005, 0.02 g)
associated with offspring birthweight.
Conclusions: Maternal PA and CRF during pregnancy were not related to infant
birthweight in overweight or obese pregnant women with a history of
preeclampsia. Our findings conflict with the inverse relationships found among
normal weight women. The limited variability in maternal PA and CRF in
pregnancy, likely consequent to the low active lifestyle led by these women, may
explain the null findings of this study. Further research is recommended given the
paucity of studies examining these relationships in overweight or obese pregnant
women.
Introduction
The average birthweight of US-born infants has increased in the U.S, over
the past 20 years(9). Higher birthweight is associated with altered growth
trajectories that predispose neonates to obesity and the associated cardiometabolic morbidities throughout their lives (3). Intrauterine energy supply is
considered the strongest predictor of fetal growth, and in excess, leads to higher
infant birthweights (10). Maternal metabolic health, defined as control of
circulating levels of blood sugars and lipids, is a major determinant of the energy
supplied to the fetus. Any loss in metabolic control results in the delivery of
increased energy supply and fetal overgrowth (5). Importantly, it is also well
established that maternal body mass is strongly and positively related to offspring
birth weight and adiposity (15). Specifically, overweight or obese mothers are
more likely to deliver larger infants. This relationship is posited to be a function of
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reduced maternal metabolic health leading to augmented fetal energy supply and
subsequent higher birthweight infants. Nearly 50% of women of reproductive age
are overweight or obese (4); as such, the exploration of modifiable factors
enabling these women to control the amount of nutrients supplied to the fetus is
critical to the health of her offspring.
Among non-pregnant populations, considerable scientific evidence
demonstrates that physical activity (PA) and cardiorespiratory fitness (CRF)
exhibit protective effects on several cardio-metabolic health outcomes (1). This is
consequent to the improvements in metabolic health (e.g., insulin sensitivity) via
adaptations to habitual PA (14). Notably, these strong effects persist in the
presence of excess adiposity. This suggests that the increased prevalence of
adverse cardio-metabolic health outcomes among overweight or obese persons
(8) may not be a result of their excess adiposity per se, but rather their lower
levels of CRF and PA. It is reasonable to suggest that this same phenomenon
operates in pregnancy, whereby the lower levels of maternal PA and CRF in
pregnancy, especially among the overweight or obese women, reduce metabolic
health, augment energy supply, and result in a larger neonate. Collectively, this
suggests that adequate levels of maternal PA and CRF may have the potential to
‘normalize’ the amount nutrients available to the fetus thereby promoting optimal
fetal growth.
Many studies have assessed maternal PA and CRF in the prenatal period
on various maternal-infant health outcomes. Several studies assessed the effects
of PA on fetal growth, with a recent review of exercise intervention trials
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concluding a significant protective effect of PA on birthweight (16). Yet, this
finding was restricted to normal-weight pregnant women, with null effects found
among their overweight or obese counterparts. The latter finding may be largely
due to a small number of rigorous intervention studies implemented among this
subpopulation. Conversely, fewer studies have assessed the effects of maternal
CRF on offspring growth during infancy. The focus of the existing studies was on
changes in maternal CRF with advancing gestation (2) and in response to
exercise training (11). As such, the scientific evidence regarding the impact of
CRF on birthweight is rather limited and equivocal; previous studies yielded
reports of positive, negative or null findings (7, 12, 17). Importantly, no studies
examining this relationship were conducted among obese pregnant women.
Taken together, the impact of CRF and PA on birthweight in overweight and
obese pregnant women is extremely limited, warranting further exploration.
Thus, the overall purpose of this study was to investigate the relationships
between maternal physical activity and cardiorespiratory fitness in the prenatal
period and infant birthweight. We addressed the purpose of this study by
evaluating the independent and joint associations of physical activity and
cardiorespiratory fitness on birthweight. We conducted a secondary data analysis
using data from a randomized exercise intervention trial implemented in a sample
of overweight or obese pregnant women.
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Methods
Study Design
The present study employed a prospective design using data drawn from
a randomized exercise comparative trial conducted between November 2001 and
July 2006. Briefly, the primary purpose of the trial was to examine the effects of
moderate intensity exercise during pregnancy on the incidence of preeclampsia
and the pathophysiological progress of preeclampsia (e.g. oxidative stress).
Secondary outcomes included maternal weight gain and birth outcomes(18).
Participant Eligibility & Recruitment
Pregnant women were recruited from nine prenatal clinics under two
medical care systems in Michigan. Women were eligible to participate in the
exercise trial if they were: 1) less than 14 weeks gestation, 2) diagnosed with
preeclampsia in a previous pregnancy, 3) had a peak oxygen consumption ≤ 50th
percentile of women in their respective age-group, and 4) participated in a
sedentary lifestyle or had a self-reported PA energy expenditure of < 840 kcals
per day. Exclusion criteria for the exercise trial were: 1) a diagnosis of chronic
hypertension or pre-gestational diabetes, 2) presence medical or physical
limitations preventing the participation in exercise, 3) physician instructions
prohibiting the engagement of prenatal exercise or 4) low mental acuity or
language barrier preventing effective communication with research staff.
Randomization and Intervention Groups
Two hundred and ten women agreed to participate in the study and 41%
(n=86) of these women did not meet the eligibility criteria. The remaining 124
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eligible participants were randomly allocated to the intervention group (n= 64) or
comparative group (n=60). The intervention group consisted of a walking
exercise program. Participants in this group were instructed to walk for 40
minutes, five times per week at a moderate intensity (55-69% maximum heart
rate). In the comparative group, participants engaged in a stretching program of
equivalent frequency and duration as compared to the exercising group, however
the women were instructed not to exceed a 10% increase in resting heart rate.
Women also performed stretching movements via videotape. All participants
wore Polar S810 heart rate monitors and wristwatch devices to validate their
adherence to the exercise or stretching programs. Further details on the
intervention and comparative groups can be found elsewhere (19). For the
purposes of this study, the data were collapsed across both groups and group
allocation was controlled for in the analyses.
Outcome Variable: Infant Birthweight
Infant weight was the dependent variable in this study and was expressed
as birthweight in grams. Infant birthweight was defined as the weight of the
neonate at the time of delivery. Data on birthweight were extracted from the
mother’s medical records.
Exposure Variables: Physical Activity and Cardiorespiratory Fitness
Daily PA was measured using a pedometer (Digiwalker SW200) attached
to an elastic belt and worn on the participants’ waist. The participants were
instructed to wear the pedometer during waking hours and to remove them
during sleep and any water-based activities (e.g., showering). Additionally, the
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participants were asked to keep a log of their total daily step counts. The
pedometers were distributed to the participants at 18 weeks of gestation and
were retrieved at the end of pregnancy (prior to delivery). For the purposes of this
study, total daily steps counts were averaged across all the available days for
each participant to provide an estimate of the average daily PA (steps per day)
during pregnancy.
Cardiorespiratory fitness was defined as peak oxygen consumption
(V̇O2peak) and estimated via a submaximal treadmill test at 17 and 28 weeks of
gestation. The exercise testing followed the Cornell Exercise Protocol. This
protocol consisted of walking on a treadmill for eight, two-minute stages with
progressive increments in speed and grade. Prior to the initiation and throughout
the exercise test, heart rate, blood pressure, fatigue, oxygen consumption,
carbon dioxide production and minute ventilation were continuously monitored.
The metabolic and respiratory markers were assessed using a portable indirect
calorimeter (VO2000, Medical Graphics Corporation, Minneapolis, MN), that was
previously validated in a sample of sedentary pregnant women (20) . Heart rate,
blood pressure and fatigue were assessed throughout the exercise-testing
period. V̇O2peak was determined by the highest amount of oxygen consumed
during the exercise test. V̇O2peak was expressed relative to participants’ body
weight as milliliters of oxygen per kilogram per minute (mL O2∙kg-1∙min-1).
Despite the evidence in the literature that CRF remains constant across
pregnancy when expressed relative to weight gain, in this sample of pregnant
women there appeared to be considerable variability in the change in CRF from
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17 to 28 weeks of gestation. As such, for the purposes of this study, CRF at
weeks 17 gestation were used to provide an estimate of the average level of
CRF in early pregnancy.
Covariate Variables: Maternal and Infant Characteristics
Maternal and infant characteristics considered potential covariates
included: maternal age, gestational weight gain (GWG), gestational age and
group allocation. Maternal age and gestational age were extracted from the
participants’ medical records. Gestational weight gain was calculated using the
participants’ objectively-measured weight at weeks 17 and 28 weeks of gestation
(Weight28 weeks – Weight17 weeks). This non-traditional expression of gestational
weight gain was used as nearly 40% of the data necessary to provide the
standard expression of gestational weight gain (weight at delivery - prepregnancy weight) was missing. Given the difficulty of women to accurately
report their pre-pregnancy weight (13) and the assumption that minimal weight is
gained in the first trimester (6), we created an additional GWG variable using the
objectively-measured weight at 17 weeks and weight at delivery (Weightdelivery –
Weight17 weeks). For the significant missing data for ‘weight at delivery’ we
performed multiple imputation. We then compared the results between both
expressions of GWG (data not shown), for all analyses performed we found each
expression exerted a similar impact on the regression coefficients and standard
errors. As such, we elected to use the objectively-measured weight gained during
17 and 28 weeks gestation. Group allocation was also considered a potential
covariate given the exposure of this intervention trial was exercise which may
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influence some of the independent variables and the outcome variable of
interest.
Statistical Analysis
The demographic, pregnancy-related and behavioral characteristics of this
sample were determined using Student’s t-tests and Pearson’s Chi-Square test.
For our analytical approach, we carried out three separate analyses using
multiple linear regression. In this study, we attempted to determine the following:
1) the independent association of PA and infant birthweight, 2) the independent
association of CRF and infant birthweight and 3) the joint associations of PA and
CRF on infant birthweight.
For each analysis, the outcome variable was birthweight, expressed in
grams. The steps to building each of these regression models were identical. We
first assessed the assumptions of linear regression and all were reasonably
satisfied. Bivariate associations between all the independent (primary and
covariates) and dependent variable were performed. To assess the independent
associations of PA and CRF on infant birthweight, the main effects were first
added to the model. Next, covariates were sequentially added. To examine the
joint association of PA and CRF, we used an interaction term between PA and
CRF. We first evaluated the joint association in an unadjusted model. Following
this, covariates were sequentially added to the model. The following variables
were expressed continuously: CRF (ml O2 ∙kg-1∙min-1), PA (steps per day),
gestational weight gain (kg), age (y), and gestational age (weeks). Group
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allocation was treated as a categorical variable. All analyses were conducted in
SAS 9.4 (Cary, North Carolina) and the significance level was set at 0.05.
Missing Data
For the purposes of this study, only women with complete data on infant
birthweight were included in the analyses. As a result, only 89 of the 124 women
participating in the study were eligible for the final analyses. To determine the
potential effects of selection bias, we tested the differences of select maternal
characteristics (age, gestational age, BMI, and gestational weight gain) between
women with complete and missing infant birthweight data. We found there to be
no significant differences, thereby providing some evidence that excluding
women without complete data on birthweight may not result in biased results.
Thus, the final sample size for the analyses of this study was 89 pregnant
women.
Results
The sample characteristics, inclusive of maternal, pregnancy and
behavior-related factors are provided in Table 2.1. At 17 weeks of gestation, the
average pregnant woman was 32 years old with a BMI classified as
overweight/obese (BMI: 29.97 ± 7.14 kg/m2). In addition, these women, on
average, delivered full-term, normal weight infants (gestational age: 38.64 ± 1.88
weeks; birthweight: 3477.48 ± 577.48g) and gained approximately 6.5 kilograms
in mid-pregnancy (17 to 28 weeks). The prevalence of macrosomia in this
sample was 14%, nearly double the current prevalence estimate of macrosomia
the United States (~8%). Only 4% of infants delivered were low-birthweight
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(<2500 g). The cardiorespiratory fitness levels of the pregnant women were low
(VO2peak: 19.85 ± 3.35 ml O ·kg
2

-1

), and considered ‘unfit’ (VO2peak: ≤ 21.0 ml O ·kg

·min-1

2

-1

)

·min-1

compared to CRF levels of similar pregnant women established by Mottola et al.
Similarly, on average, this sample accumulated 6600 steps per day, suggesting a
‘low active’ level of daily physical activity (Tudor-Locke and Bassett, 2004).
Nearly all characteristics between intervention conditions were similar with the
exception of daily PA, where the exercise condition accrued more steps per day
compared to the stretching condition (7718.19 ± 2223.78 vs 5185.53 ± 1750.39
steps/day; p<0.0001).
The adjusted linear regression coefficients for the independent
associations between CRF, PA and infant birthweight are presented in Tables
2.2 and 2.3, respectively. The independent association between CRF at 17
weeks gestation and infant birthweight did not reach statistical significance (β= 8.83 g, 95%CI: -42.2, 24.5 g), after adjusting for gestational age and weight gain,
and group allocation. Similarly, the relationship between daily PA, expressed in
steps per day, and infant birthweight (Table 2.3), was not statistically significant
(β= 0.03 g, 95%CI: -0.03, 0.08g), after controlling gestational age and weight
gain, and group allocation.
The adjusted linear regression coefficients for the joint relationship
between CRF and PA, and infant birthweight are depicted in Table 2.4. The joint
association was assessed via an interaction between CRF and PA, and was
found to not be significantly associated with infant birthweight (β= 0.006 g,
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95%CI: -0.005, 0.017 g), after adjusting for gestational age and weight gain, and
group allocation.
Discussion
Considerable evidence indicates that maternal physical activity during
pregnancy exerts a protective effect on infant birthweight. In a recent systematic
review, Wiebe et al (2015) examined the effects of 28 PA interventions during the
prenatal period on infant birth size. The conclusion of this review was that women
participating in higher levels of maternal PA delivered lighter infants. These
protective effects however, occurred only in normal weight pregnant women (22).
Because nearly 50% of women of reproductive age are overweight or obese (7)
and possess the greatest risk of delivering heavier infants (6), we thought it
important to determine if a protective effect existed in overweight or obese
pregnant women. Thus, in the present study, we examined the association
between maternal PA in pregnancy and infant birthweight in a sample of
overweight or obese pregnant women. The major finding of this study was that, in
overweight and obese pregnant women, PA was not associated with infant
birthweight.
Our observation that maternal physical activity was not associated with
infant birthweight in overweight or obese pregnant women is consistent with the
limited number of previous studies assessing this relationship in this group (14,
16, 18). For example, Nascimiento et al. (2012) examined the effects of a weekly
supervised, light-to-moderate intensity exercise program on several maternalinfant outcomes including infant birthweight. Similarly, Oostdam et al. (2012)
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assessed the effects of a bi-weekly moderate intensity aerobic and strengthtraining exercise program on maternal metabolic health (i.e. blood glucose and
insulin sensitivity) and infant birthweight weight. Lastly, Ruiz et al. (2013)
examined the effects of a light-to-moderate intensity exercise program consisting
of aerobic and strength exercises, performed three times per week. Collectively,
these studies found that maternal physical activity was not associated with infant
birthweight. This conflicts with the established inverse relationship found in
normal weight pregnant women. A possible explanation for the conflicting
evidence between these subpopulations is that the dose of PA was insufficient to
influence infant birthweight. An obvious difference in these studies is the fact that
overweight or obese women possess more fat mass. Consequently, increased
adiposity and elevated blood lipids are posited to be one of the mechanisms
leading to greater nutrient supply to the fetus, resulting in higher birthweights (8,
12) . Strong evidence indicates that physical activity inversely associates with
blood lipid levels (1, 10). As such, the amount of PA necessary to affect these
levels in overweight or obese pregnant women, and thereby significantly impact
infant birthweight, may be considerably higher than the levels of PA exhibited in
this sample and those in previous studies.
Currently, the U.S. Physical Activity Guidelines, with concurrence from the
American College of Obstetricians and Gynecologists (4, 20) , recommend that
pregnant women engage in 150 minutes per week of moderate-intensity aerobic
and strength-training activities throughout pregnancy. Given the low amount of
physical activity achieved by the pregnant women in this sample, it is likely they
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did not meet the current recommendations. However, the physical activity
prescribed in the aforementioned studies (14, 16, 18) appears to exceed this
recommendation yet, infant birthweight remained unaffected across all studies.
From these findings, two important observations can be made. First, the doses of
physical activity levels in the current and other studies may have been insufficient
to impact birthweight, suggesting that a higher dose of PA may be required.
Second, given that the dose of PA prescribed in these studies exceeded the
current PA guidelines, revised recommendations specific to overweight or obese
pregnant women may be necessary. However, given the paucity of studies
conducted in this population, more research assessing the effect of various
doses of PA on infant size are essential to ascertain the existence of an effect.
Another possible explanation for the null association found in this present
study is low variability in PA levels. In this study, the average daily steps
accumulated was 6579.91 steps with a SD of 2379.17 steps. While the variability
in daily PA in this study is higher compared to previous studies (9), this amount
may have been insufficient to detect an effect. Limited variability in the
independent variable may result in a loss of power, thus reducing the likelihood
of finding a statistically significant association (17). The reduced variability in PA
found in this sample, may be result of strict eligibility criteria imposed during
participant recruitment. Specifically, these women had a history of preeclampsia,
which affects between 3 and 10% of all pregnancies (21). Common
characteristics of women with preeclampsia are overweight or obesity and
sedentarism (11, 15). Given the selective population from which these women
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were drawn, it is not surprising that their daily PA patterns were similar,
consequently reducing variability in this behavior. In addition, the small sample
size in this study likely reduced our statistical power, potentially explaining our
null findings.
This study was novel in that it was the first to examine the association
between maternal cardiorespiratory fitness and birthweight in a sample of
overweight or obese pregnant women. The scientific knowledge on this
relationship is non-existent in this group as previous studies limited their samples
to normal weight pregnant women and reported conflicting effects on infant
birthweight. Based on the strong metabolic effects of physical activity and posited
influence on fetal nutrient supply (2), we hypothesized that maternal
cardiorespiratory fitness, an indicator of habitual physical activity, would inversely
associate with birthweight. However, the findings of this study demonstrated that
maternal CRF appears not to influence infant birthweight. A potential explanation
for the lack of an association demonstrated in this study may be limited variability
in the levels of CRF in the study sample. Few studies have assessed CRF in
overweight or obese pregnant women. Collectively, these studies have indicated
reduced variability in the levels of CRF in this group. Mottola et al. (2006)
measured CRF among an anthropometrically diverse sample of pregnant women
(13) . The average CRF, expressed as peak oxygen consumption, was 23.7 ml
O2·kg-1·min-1 with a standard error (SE) of 5.0 ml O2·kg-1·min-1. In a similar study,
Davenport et al. (2008), assessed the CRF of overweight and obese pregnant
women (5). Compared to CRF values found in the former study, lower levels of
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CRF (21.6 ml O2·kg-1·min-1) and reduced variability (SE: 3.8 ml O2·kg-1·min-1)
were found among overweight and obese pregnant women. The lower levels of
CRF found in the latter study are similar to those found in our study with an
average CRF of 19.85 ml O2·kg-1·min-1 and SE of 3.35 ml O2·kg-1·min-1. While
low variability may be inherent in this specific subpopulation (i.e. history of
preeclampsia, sedentarism), the additional requirement of a low fitness level (<
50th percentile) likely further reduced the variability in cardiorespiratory fitness
levels. Consequently, the limited variability potentially precluded our ability to
ascertain an effect through a loss in statistical power.
This study has strengths and limitations. First, to our knowledge, this is the
first study to address the independent and joint associations between maternal
PA and CRF and infant birthweight, in a sample of overweight or obese pregnant
women. Given the well-documented health benefits of CRF and PA, the
investigation of its potential influence on maternal-fetal health was warranted.
Second, objective measures of PA and CRF were used in this study, thus
reducing biases associated with subjective assessments (e.g. self-report) (3). In
addition to these significant strengths and the aforementioned limitations (i.e.
limited variability, poor adherence/compliance), this study has other limitations.
First, while our sample is one of the largest available that includes measures of
PA, CRF and birthweight (i.e., n=89), it may have been too small to detect an
association. The recruitment and retention of pregnant women, especially the
overweight or obese subpopulation, is a considerable challenge in this field; poor
study adherence is common. Second, we did not consider other potential health
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behaviors that have been documented to influence infant size, including maternal
diet (23). Third, the use of birthweight as a measure of fetal growth may have
resulted in our inability to capture important changes in tissue composition and
future health risks (2). Evidence indicated that PA and exercise may yield
significant differences in tissue composition with no differences found in
birthweight (19).
In conclusion, the scientific evidence regarding the relationships between
PA, CRF and birthweight is limited, especially among overweight and obese
pregnant women. This study is the first provide important information regarding
these relationships and contributes to this rapidly advancing area of research.
Nonetheless, before any definitive conclusions are drawn from the findings of this
study, further research is warranted. To address the aforementioned limitations
of this study, future investigators should consider employing sampling strategies
(e.g. purposive sampling) that may increase variability in the levels of maternal
PA and CRF. Additionally, the development of novel strategies to enhance
recruitment and retention should be encouraged given the established issues
with the overweight and especially the obese subpopulations. Lastly, the
underlying mechanisms that are posited to explain the relationships between
physical activity and cardiorespiratory fitness and birthweight, such as maternal
metabolic health and the associated biomarkers, are often neglected in these
studies. Accordingly, we strongly recommend that future researchers collect data
on the metabolic profiles of their study population. In closing, this study provide
evidence that neither maternal PA nor CRF in the prenatal period are associated

49

with birthweight. However, given the established inverse relationship between PA
and birthweight in normal weight pregnant women, we recommend further
investigation into these potential relationships in overweight or obese pregnant
women.
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Table 2.1. Maternal and infant sample characteristics, by total and intervention group
Sample Characteristics
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N

Total (n=90)
Mean
SD

N

Exercise (n=49)
Mean
SD

N

Stretching (n=41)
Mean
SD

Maternal a
Age (y)
Weight (kg)
Height (m)
Body Mass Index (kg/m2)
Gestational Weight Gain *
CRF (ml O2∙kg-1∙min-1) b
Physical Activity (steps/day)
No. Days Monitored

90
90
90
90
90
90
89
89

32.3
80.4
1.6
30.0
6.45
19.9
6579.9
114.2

4.7
18.7
0.1
7.1
3.6
3.4
2379.2
32.6

49
49
49
49
49
49
49
49

32.5
79.9
1.6
29.7
6.0
20.0
7718.2**
114.6

21.5
19.1
0.1
7.5
2.9
3.1
2223.8
32.6

41
41
41
41
41
41
40
40

32.1
81.0
1.6
30.3
7.0
19.7
5185.5
113.6

4.9
18.4
0.1
6.8
4.2
3.6
1750.4
33.0

Infant
Gestational Age (weeks)
Birthweight (g)
Macrosomia (%)

90
90
90

38.64
3477.48
14.44

1.9
577.5
-----

49
49
49

38.5
3475.5
7.8

2.0
613.4
-----

41
41
41

38.8
3479.9
6.7

1.7
538.6
-----

Note: a Demographic characteristics (age, weight, height, and body mass index) are reported at 17 weeks gestation.
*Gestational weight gain represents weight gain during 17 weeks and 28 weeks of gestation (corresponding to
participant laboratory visits). **denotes significant between-group differences (p<0.0001). **For all behavioral
characteristics (cardiorespiratory fitness [CRF], physical activity and number of days monitored) average values were
calculated using all available time points throughout pregnancy: CRF (17 weeks), PA steps/day and days monitored
(17 weeks until delivery).

Table 2.2. Adjusted linear regression coefficients assessing the independent
association between CRF and birthweight (g).
Parameter Estimates
Predictors
Primary Exposures
CRF (ml O2∙kg-1∙min-1)
Covariates
Maternal Age (y)
Gestational Age (weeks)
Gestational weight gain*
Group Allocation**
Exercise

β

SE

p-value

-8.83

16.77

0.6000

7.56
144.98
10.64

12.13
30.14
7.30

0.5347
<0.0001
0.1485

60.54

112.38

0.5915

*Gestational weight gain represents weight gain during 17 weeks and 28 weeks
of gestation (corresponding to participant laboratory visits). **Stretching is the
referent group.
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Table 2.3. Adjusted linear regression coefficients assessing the independent
association between average PA (steps/day) in pregnancy and birthweight (g).
Parameter Estimates
Predictors
Primary Exposures
Average PA (steps/day)
Covariates
Maternal Age (y)
Gestational Age (weeks)
Gestational weight gain*
Group Allocation**
Exercise

β

SE

p-value

0.03

0.03

0.3037

7.53
144.28
10.76

12.06
29.97
7.24

0.5342
<0.0001
0.1408

-16.06

131.98

0.9304

*Gestational weight gain represents weight gain during 17 weeks and 28 weeks of
gestation (corresponding to participant laboratory visits). Note: No. of PA days
represents the number of days the pedometer was worn during pregnancy.
**Stretching is the referent group.
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Table 2.4. Adjusted linear regression coefficients assessing the joint association
between average PA (steps/day) and CRF in pregnancy and birthweight (g).
Parameter Estimates
Predictors
Primary Exposures
Average PA (steps/day)
CRF (ml O2∙kg-1∙min-1)
Average PA*CRF
Covariates
Maternal Age
Gestational Age
Gestational weight gain*
Group Allocation**
Exercise

β

SE

p-value

-0.09
-52.24
0.006

0.12
41.44
0.006

0.4441
0.2111
0.2929

7.38
143.64
11.28

12.11
30.17
7.31

0.5439
<0.0001
0.1268

-9.30

132.75

0.9443

*Gestational weight gain represents weight gain during 17 weeks and 28 weeks of
gestation (corresponding to participant laboratory visits). **Stretching is the
referent group.
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CHAPTER 3
ASSOCIATION BETWEEN CHANGE IN MATERNAL PHYSICAL ACTIVITY
DURING PREGNANCY AND INFANT SIZE
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Abstract
Purpose: Significant evidence demonstrates that maternal physical activity (PA)
decreases in the prenatal period. Declines in PA are known to produce adverse
metabolic effects. The neonatal consequences of these decrements in maternal
PA are largely unknown. Previous studies assessing the relationship between
maternal PA and infant birthweight failed to account for the natural changes in
PA that occur throughout pregnancy. Therefore, the purpose of this study was to
describe the relationship between changes in prenatal PA and infant birthweight.
Methods: This study employed a prospective design using data from a
randomized controlled exercise intervention trial conducted in sedentary,
overweight or obese pregnant women with a history of preeclampsia. Women
with complete data for infant birthweight, peak oxygen consumption, and daily PA
measured via a pedometer (17 weeks to delivery) were included in the analyses.
Individual trajectories for prenatal PA were estimated via repeated measures
analyses to represent the change in PA from mid-to-late pregnancy. Multiple
linear regression models were then performed to determine the association
between change in prenatal PA and birthweight. Gestational age, weight gain,
maternal age and group allocation were covariates.
Results: Eighty-nine pregnant women were included in this study and were, on
average, 32 years old, overweight/obese (BMI 29.97 ± 7.14 kg/m2) and lowactive (6,579.91 ± 2379.17 steps/day). PA declined from the 4th to the 8th month
of pregnancy (-399.73 ± 371.38 steps∙day-1∙month-1). After adjusting for
covariates, multiple linear regression analyses showed that the decline in
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prenatal PA (β= -0.28 g, 95%CI: -0.70, 0.25 g, p=0.35) was not associated with
birthweight. In addition, CRF (β= 0.04 g, 95%CI: -0.06 g, 0.14 g, p=0.697) did not
exhibit a moderating effect.
Conclusions: The findings of this study demonstrated that maternal PA
decreased from mid to late pregnancy. The observed decline was unrelated to
infant birthweight. Future investigations employing more rigorous measurements
of PA are recommended.
Introduction
Over the past two decades, increases in mean birthweight and the
prevalence of large-for-gestational age neonates have been documented in the
U.S. and other developed countries (4, 20). Several adverse health outcomes are
associated with higher birthweight, including an increased risk of obesity and
related co-morbidities in later life (8). Considerable evidence demonstrates that
higher levels of physical activity (PA) during pregnancy are associated with lower
infant birthweight (6, 30). This relationship is posited to be a function of the
strong metabolic effects of PA (16, 27), whereby an active mother is better able
to control the amount of energy supplied to her fetus (1).
Despite the well-established metabolic benefits of PA, recent evidence
indicates that over the past 50 years population trends in maternal physical
activity have exhibited persistent declines (2). In addition to the population
trends, research has demonstrated that maternal physical activity decreases
throughout pregnancy (17, 24), with the most precipitous declines observed in
the 3rd trimester. Declines in PA are known to result in adverse metabolic effects
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including impaired control of serum glucose and lipids. Given these trends,
decreased maternal PA is a plausible explanation for the rise in the prevalence of
larger infants (1, 3).
While reductions in PA during pregnancy are universal across all
subgroups of pregnant women, overweight or obese women are the least active
group (17, 24). Heavier women have an increased risk of excessive gestational
weight gain, thereby potentially exacerbating the decline in maternal PA leading
to fetal overgrowth and larger neonates (19, 23, 28). This observation is
supported by increased delivery of larger neonates among overweight or obese
women (12) . Evaluating the association between the decline in maternal PA and
neonatal birthweight in this subgroup is important given the increasing
prevalence of obesity in women of reproductive age (13).
Currently, no prospective studies have evaluated the relationship between
the change in maternal physical activity during pregnancy and neonatal
birthweight. Most studies have examined the relationship between average level
of maternal physical activity across pregnancy or during specific trimesters and
infant size (6). Consequently, these studies failed to account for the naturally
occurring changes in physical activity. As such, the associations of the changes
in maternal physical activity across the prenatal period and infant birthweight are
largely unknown. In addition, no studies have evaluated the potential modifying
effect of maternal cardiorespiratory fitness (CRF) on the relationship between
change in maternal PA and infant birthweight. CRF is an indicator of habitual
physical activity as such, women with higher levels of maternal CRF may protect
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against the negative metabolic effects of decreasing levels of PA. Thus, the
primary purpose of this study was to describe the relationship between changes
in physical activity in mid-to-late pregnancy and infant birthweight, in a sample of
overweight or obese pregnant women. A secondary purpose of this study was to
evaluate the potential modifying effect of maternal cardiorespiratory fitness on
this relationship.
Methods
Study Design
The present study employed a prospective design using data from a fiveyear randomized exercise comparative trial (RCT). This RCT was designed to
assess the effects of a moderate exercise program in the prenatal period on the
incidence of preeclampsia its pathological processes (e.g., oxidative stress). The
secondary purpose of the study was to assess the effects of exercise on
gestational weight gain and birth outcomes (31) .
Participant Eligibility & Recruitment
Pregnant women were recruited from nine prenatal clinics in Michigan.
Women were enrolled in this intervention trial if they were 1) less than 14 weeks
gestation, 2) history of preeclampsia, 3) had a peak oxygen consumption of ≤
50th percentile of women in their respective age-group, 4) had a sedentary
lifestyle or had a self-reported physical activity energy expenditure of less than
840 kcals per day. Women were excluded if they had: 1) chronic hypertension or
pre-gestational diabetes, 2) medical or physical limitations that inhibit
participation in exercise, 3) been advised against the participation in prenatal
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exercise by a physician or 4) a low mental acuity and/or language barrier
preventing effective communication with research staff.
Randomization & Intervention Groups
Two-hundred and ten pregnant women expressed interest in participating
in the RCT, however 41% (n=86) did not meet the eligibility criteria. The
remaining eligible pregnant women (n=124) were randomly assigned to an
exercise program (n=64) or a stretching program (n=60). The exercise program
recommended that the women walk for 40 minutes, five times per week at
moderate intensity (55-69% of heart rate reserve). In the stretching program,
participants were instructed to mimic the movements of a stretching video of
equivalent frequency and duration as the exercise program. With regard to
intensity, the participants were instructed to not increase their heart rate more
than 10% above resting levels. To monitor compliance to the exercise intensity of
each program, the participants wore Polar S810 heart rate monitors and
wristwatch devices. More details on the exercise and stretching programs of the
RCT can be found elsewhere (32). For the purposes of this study, data were
collapsed across the two groups and group allocation was controlled for in the
analyses.
Outcome Variable: Infant Birthweight
Infant birthweight, in grams, was the dependent variable in the present
study. Birthweight was defined as the weight of the infant at the time of delivery.
The data on birthweight was extracted from the mother’s medical records.
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Exposure Variables:
Change in Physical Activity
Physical activity was assessed daily using a pedometer (Digiwalker
SW200) from weeks 18 gestation until delivery. Each participant was instructed
to wear the pedometer, attached via an elastic belt and worn directly above the
right hip, during waking hours. Participants were to remove the pedometer prior
to sleeping and participation in any water-based activities (e.g. showering,
swimming). In addition, participants were asked to keep a daily record of their
total daily step counts throughout their prenatal period. Daily steps were
collapsed into four-week periods that corresponded to the months of pregnancy:
month 4 (18 – 21 weeks), month 5 (22 – 25 weeks), month 6 (26 – 29 weeks),
month 7 (30 – 33 weeks), and month 8 (34 – 37 weeks). Nearly 60% of data on
daily step counts were missing in 9th month of pregnancy (38 – 41 weeks), likely
due to delivery, so we excluded this month from the analysis. Prenatal PA was
expressed as steps·day-1·month-1. We did not employ any exclusionary protocols
for the PA data. The amount of steps accumulated in pregnancy ranged from 0 to
16,503 steps per day. Change in prenatal physical activity was determined using
individual trajectories in PA across the prenatal period (i.e. time) [see Statistical
Analysis].
Cardiorespiratory Fitness
Cardiorespiratory fitness was defined as peak oxygen consumption
(V̇O2peak) and expressed relatively as milliliters of oxygen per kilogram per minute
(ml O2 ∙ kg-1 ∙ min-1). V̇O2peak was estimated via a submaximal treadmill test at 17
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and 28 weeks gestation. The treadmill exercise test followed the Cornell Exercise
protocol, a modified version of the Bruce Protocol Treadmill Test. The protocol
consisted of each participant walking on a treadmill through eight, two-minute
stages with progressive increments speed and grade. Prior to the test, resting
levels of heart rate, blood pressure, fatigue, oxygen consumption, carbon dioxide
production and minute ventilation were assessed. These same parameters were
continuously monitored throughout the exercise test using a portable indirect
calorimeter (VO2000, Medical Graphics Corporation, Minneapolis, MN). This
device has been previously validated in a sample of sedentary pregnant women
(33). Although in the scientific literature CRF is shown to not change significantly,
the change in CRF levels between 17 and 28 weeks in this sample were quite
variable. As such, for the purposes of this study, CRF at 17 weeks gestation was
used to provide an estimate of the average CRF level in early pregnancy.
Covariate Variables: Maternal and Infant Characteristics
Several maternal and infant characteristics that may affect birthweight, PA
and/or CRF were included as potential covariates. Maternal and infant
characteristics included the following: age, gestational weight gain (GWG),
gestational age and group allocation. Maternal age (in years) and gestational age
(in weeks) were extracted from the participants’ medical records. Gestational
weight gain in this study was calculated using a non-traditional approach. We
used the difference in the weights that were objectively measured at 17 and 28
weeks gestation to express gestational weight gain. GWG was not expressed
using the traditional expression, difference in the weight at delivery and pre-
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pregnancy weight, because nearly 40% of the data for either of these metrics
was missing. However, to compare our non-traditional expression of GWG to a
more standard expression, we created an additional GWG variable that
represented the difference in weight from 17 weeks gestation to delivery.
Because it is assumed that minimal weight is gained in the first trimester (18) and
self-reported pre-pregnancy is prone to significant error (26), we found it more
appropriate to use the weight at 17 weeks gestation. To create this additional
GWG variable, we performed multiple imputation for the ‘weight at delivery’ and
then calculated the GWG variable. After this, we compared the results of the
multiple regression analyses (see statistics section) for both expressions of GWG
(data not shown). We found that each GWG variable impacted the regression
coefficients and standard errors similarly. As a result, we elected to use the
weight gained from 17 to 28 weeks gestation to represent GWG.
Statistical Analyses
Group differences in the maternal and infant characteristics between the
exercise and stretching programs were determine using Student’s t-test and
Pearson Chi-square tests. For the main analyses, we performed two multiple
linear regression models. In this study, we sought to determine: 1) the effects of
change in maternal physical activity in mid-to-late pregnancy on infant birthweight
and 2) the modifying effect of CRF on the association between change in PA
during pregnancy and infant birthweight. Change in PA in the prenatal period was
determined using individual trajectories in PA across time. We performed a
random intercept and slope mixed model with repeated measures to estimate
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intercepts and slopes of each participant. These estimates were then created as
individual variables with the intercept acting as a ‘baseline measure of PA’ and
the slope representing the ‘change in PA’ across the prenatal period.
For each analysis, infant birthweight was the dependent variable. In the
first main analyses, change in maternal PA during pregnancy was the primary
independent variable. In the second main analyses, change in maternal PA
during pregnancy and CRF were the primary independent variable and modifying
variable, respectively. In the latter analyses, we assessed the modifying effect
with an interaction term between CRF and change in maternal PA in pregnancy.
We first assessed the assumptions of linear regression and no major violations
were found. Next, bivariate associations between all the independent variables
(primary and secondary) and the outcome variable were performed. Following
this, unadjusted multiple linear regression models were performed first, followed
by a sequential inclusion of covariates. All analyses were conducted using SAS
analytical software version 9.4 (Cary, North Carolina) and the significance level
was set at α = 0.05. The following variables were express continuously: change
in prenatal PA (steps ∙ day-1 ∙ month-1), CRF (ml O2 ∙ kg-1 ∙ min-1), GWG (kg), age
(years), gestational age (weeks). Group allocation was treated as a categorical
variable with the stretching program treated as the referent group.
Missing Data
For the purposes of this study, only women with complete data on infant
birthweight, maternal PA in pregnancy and cardiorespiratory fitness were
included in the analyses. As such, only 89 of the 124 eligible pregnant women
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were used in the analyses. To assess the possibility of selection bias, we
compared the differences in demographics, pregnancy-related and behavioral
characteristics of women with and without complete data. We found no significant
differences between these groups, thus providing some evidence that excluding
these women may not provide biased estimates.
Results
Table 3.1 presents maternal, prenatal and behavior-related characteristics
of this study sample. At 17 weeks of gestation, the average pregnant woman was
32 years old with a BMI classified as overweight/obese (BMI: 29.97 ± 7.14
kg/m2). On average, women delivered full-term, normal weight infants
(gestational age: 38.64 ± 1.88 weeks; birthweight: 3477.48 ± 577.48g). The
average weight gained in mid-pregnancy (17 to 28 weeks) was approximately 6.5
kilograms. Roughly 14% of infants were born macrosomic, nearly double the
prevalence in the United States (~8%) (20). Only 4% of infants delivered were
low-birthweight (<2500 g). Women in this sample were considered ‘unfit’ with an
average VO2peak of 19.85 ml O2·kg-1·min-1 (SD 3.35). In addition, these women
accumulated, on average, 6600 steps per day, suggesting participation in a ‘low
active’ lifestyle (Tudor-Locke and Bassett, 2004). In addition, during every month
of pregnancy, PA decreased, on average, by nearly 400 steps per day.
Specifically, Table 3.2 shows the patterns in maternal PA from mid-to-late
pregnancy. As expected, maternal PA declined from month 4 (18 – 22 weeks) to
month 9 (38 – 41 weeks), with women accumulating on average 7227.7 (±
2618.5) steps·day-1 and 5848.5 (± 2778.9) steps·day-1), respectively.
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Additionally, this table shows that the number of pregnant women recording their
daily PA declined as well, most precipitously in the last month of pregnancy.
The adjusted linear regression coefficients for the association between
change in prenatal PA and infant birthweight are presented in Table 3.3. Change
in prenatal PA was not significantly associated with infant birthweight (β= -0.28 g,
95%CI: -0.70, 0.25 g, p=0.35), after adjusting for maternal age, gestational age,
weight gain, and group allocation.
Table 3.4 depicts the adjusted linear regression coefficients for the
modifying effect of CRF on the relationship between the change in PA and infant
birthweight. The interaction between CRF and change in PA and was not
significantly associated with infant birthweight (β= 0.04 g, 95%CI: -0.06 g, 0.14 g,
p=0.697), after adjusting for maternal age, gestational age, weight gain, and
group allocation.
Discussion
The primary finding of this study was that, in overweight or obese women,
the decrease in maternal physical activity from mid- to late-pregnancy was
unrelated to infant birthweight. This study was unique in that it was the first to
prospectively follow women from mid- to late-pregnancy and evaluate the
association between change in physical activity and infant birthweight. Previous
prospective studies assessing this relationship limited their evaluation to the
average level of physical activity across pregnancy or during specific trimesters
in pregnancy (6, 17). Thus, this study provides a unique examination of the
relationship between the decline in PA during pregnancy and infant birthweight.
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Moreover, this study was conducted in a sample of overweight or obese pregnant
women, an understudied population. Further research is necessary in this group
as these women are predisposed to excessive weight gain, low levels of PA and
poor metabolic health, all of which are posited to be risk factors for the delivery of
larger neonates.
A potential explanation for the null association between the change in
maternal PA and infant birthweight is the small magnitude in the change in PA
from mid-to late-pregnancy. In this study, a very modest reduction in maternal PA
was observed likely consequent to the low active lifestyle led by these women,
potentially demonstrating a floor effect. At 17 weeks gestation (i.e. baseline) this
sample of women accumulated nearly 6600 steps·day-1·month-1, which is
reflective of low activity. A majority (~3000 – 4000 steps) of these daily step
counts were likely the results of everyday activities of daily living [ADLs] (29). The
remainder potentially represented leisure time physical activity. Considering the
necessity of the engagement in ADLs, PA attributed to ADLs likely did not
change significantly during pregnancy. As such, the decrements in PA
documented in this study were likely consequent to reductions in leisure-time
physical activity (14). On average, the women in this sample decreased their
daily steps per month by approximately 400 steps (-399.73 ± 371.38 steps) from
the 4th month to the 8th month of pregnancy. Over a 5-month period, this
corresponds roughly to a 2,000-daily step decrement over a 5-month period. This
minimal change is consistent with previous studies. For example, Renault et al.
(2010) assessed physical activity via pedometers and found an 1,850-step
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decrement in steps per day from 13 weeks to 36 – 38 weeks gestation in obese
women (24). The small magnitude of the decrement in maternal PA found in this
study was likely insufficient to influence fetal energy supply and birthweight,
thereby precluding our ability to detect an association.
In support of this interpretation, Clapp et al. (2002) evaluated the effects of
various doses of prenatal physical activity in normal weight women on infant size
(10). They found that women who decreased their PA delivered heavier, fattier
neonates reflected by higher birthweight and greater amounts of adipose tissue
compared to women who maintained or increased their PA throughout the
prenatal period. The considerable decrement in PA likely altered fetal energy
supply, especially in the 3rd trimester. This is consequent to the reduction in the
maternal skeletal muscle demand for energy, thus increasing energy availability
to the fetus (22). The decrement in PA experienced by these women was 200
minutes per week, a markedly greater reduction in the levels of PA relative to the
400-daily step per month decline exhibited in the present study. As such, a larger
decrement in prenatal PA may have been necessary to affect infant size.
Another unique aspect of this study was the examination of the
moderating effect of maternal cardiorespiratory fitness on the relationship
between the change in maternal PA during pregnancy and birthweight.
Cardiorespiratory fitness is an indicator of habitual physical activity (7). In
addition, given the strong metabolic effects of physical activity (27), we posited
that maternal CRF may attenuate the potential adverse effects (i.e. reduced
metabolic health) related to reductions in prenatal PA (5) on neonate size. The
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findings of the aforementioned study of Clapp et al. (2002) support this
hypothesis. The women in that study were previously active and subsequently
possessed optimal levels of cardiorespiratory fitness. Despite the increased
birthweight and adipose tissue among neonates born to the women who
decreased their prenatal PA during the prenatal period, the birthweight and tissue
composition of these neonates were still within the normal range (9). This may
indicate that higher levels of PA and thus, CRF in the preconception period may
have protected the neonate from overgrowth in spite of a decline in maternal PA
during pregnancy. In this study, however, we observed that maternal
cardiorespiratory fitness does not moderate the relationship between the decline
in maternal PA in the prenatal period and infant birthweight.
A possible explanation for the null observation regarding the moderating
effects of maternal cardiorespiratory fitness is low variability. Previous studies
assessing CRF levels in pregnancy observed low variability among the
overweight or obese subpopulation. Davenport et al. (2008), assessed the CRF
of overweight and obese pregnant women and found the average CRF,
expressed as peak oxygen consumption, of 21.6 ml O2·kg-1·min-1 (± 3.8 ml O2·kg1·min-1)

(11). The average value and variability (i.e. standard deviation) is lower in

comparison to those found in an anthropometrically diverse sample of pregnant
women by Mottola et al. (2006). These authors found an average CRF of 23.7
ml O2·kg-1·min-1 and SE of 5.0 ml O2·kg-1·min-1 (21). The lower levels of CRF
found in the former study are similar to those found in the present study (VO2peak:
19.85 ± 3.35 ml O2·kg-1·min-1). The low variability in CRF found in this study may
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be due to the low-active lifestyles led by these women. Habitual PA is a strong
predictor of CRF and as such, the low levels of PA found among this sample of
women likely resulted in low levels and variability of CRF. In addition, the
combination of limited variability in maternal CRF and the small magnitude of the
change in PA during pregnancy may have precluded our ability to detect a
moderating effect (25).
This study has strengths and limitations. Importantly, this is the first study
to examine the association between the changes in maternal physical activity in
mid-to-late pregnancy and infant birthweight in a sample of overweight or obese
pregnant women. In addition, this study is the first to assess the potential
moderating effect of maternal cardiorespiratory fitness on this relationship. An
additional strength of this study is the longitudinal measurement of physical
activity in the prenatal period. This evaluation allowed us to account for the
natural changes in PA from mid-to-late pregnancy and led to a more accurate
estimation of its relationship with infant birthweight. Lastly, the use of objective
assessments increased the precision of the measurement of physical activity and
cardiorespiratory fitness. In addition to these significant strengths, this study has
limitations. First, only PA in mid-to-late pregnancy was observed. Thus, any
changes occurring prior to 17 weeks of gestation were missed, potentially
resulting in a less accurate representation of the changes in PA during
pregnancy. Second, the sample size for this study was small (n=90) possibly
limiting our ability to detect an association, especially a moderating effect. Third,
we did not consider other potential health behaviors that have been documented
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to influence infant size, including maternal diet (34). Fourth, while birthweight is
the most widely used measure of infant size, it fails to provide information on the
tissue composition of the neonate, which is important to future health risks (15).
In conclusion, this study demonstrated that the decline in maternal
physical activity during the prenatal period was unrelated to birthweight. In
addition, we observed that maternal cardiorespiratory fitness did not moderate
the association between the decline in maternal PA during pregnancy and infant
birthweight. In spite of these null observations, this study contributes to this
rapidly growing area of research in an understudied and important subpopulation.
Several recommendations are suggested to address the limitations of this study
that will ensure higher quality assessments of these relationships in future
investigations. First, the employment of sampling strategies aimed to increase
the variability in PA and CRF (i.e. purposive sampling) are encouraged. Second,
while pedometers provide an objective assessment of physical activity, they are
limited to providing information on PA volume. Consequently, pedometers are
unable to capture other important components of PA such as intensity. Intensity
of PA may be an important factor to fetal growth given its strong relation to
metabolic health. Third, future research should include the assessment of
metabolic biomarkers, such as glycemic and lipidemic control, as these
parameters are considered the underlying mechanisms to excessive fetal growth
and are often ignored in studies. Lastly, more precise measurements of infant
anthropometry are needed (i.e. lean and fat mass) as these are important to
future health risks of the offspring. In closing, the findings of this study provide no
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evidence that the declines in maternal PA during mid-to-late pregnancy are
related to infant birthweight and that maternal CRF exerts a moderating effect on
this relationship.
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Table 3.1. Sample characteristics of pregnant women, by total and intervention group

N

Total
(n=90)
Mean

N

Exercise
(n=49)
Mean

SD

N

Stretching
(n=41)
Mean
SD

SD

90
90
90
90

32.3
80.4
1.6
30.0

4.7
18.7
0.1
7.1

49
49
49
49

32.5
79.9
1.6
29.7

4.4
19.1
0.1
7.5

41
41
41
41

32.1
81.0
1.6
30.3

4.9
18.4
0.1
6.8

90
90
90
90

38.6
6.5
3477.5
14.4

1.9
3.6
577.5
-----

49
49
49
49

38.5
6.0
3475.5
7.8

2.0
2.9
613.4
-----

41
41
41
41

38.8
7.0
3479.9
6.8

1.7
4.2
538.6
-----

90
89

19.8
6588.7

3.4
2416.6

49
49

20.0
7801.4**

3.1
2236.4

41
40

19.7
5103.1

89
89

-399.7
114.2

371.4
32.6

49
49

-470.6**
114.6

374.1
32.6

40
40

-312.9
113.6

3.6
1706.
0
353.4
32.96

Maternal and Infant
Characteristics
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Demographics
Age (y)
Weight (kg)
Height (m)
Body Mass Index (kg/m2)
Pregnancy-Related
Gestational Age (weeks)
Gestational Weight gain*
Birthweight (g)
Macrosomia (%)
Behavioral¥
CRF
Physical Activity
Change in PA
No. Days Monitored

Note: *Gestational weight gain represents weight gain during 17 weeks and 28 weeks of gestation
(corresponding to participant laboratory visits). **denotes significant between-group differences
(p<0.0001). ¥ PA data on one participant was removed as no data on PA wwere available, however all

other pertinent data were available. CRF was expressed as ml O2∙kg-1∙min-1. Physical activity was
expressed as steps∙day-1∙month-1
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Table 3.2. Maternal patterns of average physical activity (steps·day-1) from mid-to-late pregnancy,
by group
Total
Mean
Gestation* N
Month 4
87 7227.7

84

Month 5

86 7093.6

Month 6

85 6614.4

Month 7

84 6135.2

Month 8

75 5797.2

Month 9

37 5848.5

SD
(range)
2618.5
(2426.6-16503.2)
2679.5
(1987.8-17526.3)
2551.1
(1705.9-15788.6)
2618.1
(186.7-15627.4)
2521.4
(598.6-14033.9)
2778.9
(1302.0-14133.5)

Exercise
Mean

8726.3
8333.6
7852.6
7407.9
6814.8
6666.4

SD
(range)
2246.8
(4369.2-16503.2)
2574.2
(376306-17526.3)
2412.9
(4020.7-15788.6)
2466.9
(3400.7-15627.4)
2408.4
(1915.0-14033.9)
3121.9
(1858.0-14133.5)

Stretch
Mean

5465.5
5599.2
5082.9
4666.7
4569.9
4886.3

SD
(range)
1809.3
(2426.6-9922.4)
1960.9
(1987.8-9867.11)
1783.3
(1705.9-8140.1)
1947.7
(186.7-8260.2)
2094.5
(598.6-8517.6)
1995.3
(1302.00-8315.0)

Note: *The weeks of gestation that correspond to each month of pregnancy are as follows: Month 4
(18 – 21 weeks), Month 5 (22 – 25 weeks), Month 6 (26 – 29 weeks), Month 7 (30 – 33 weeks),
Month 8 (34 – 37 weeks) and Month 9 (38 – 41 weeks)

Table 3.3. Adjusted linear regression coefficients assessing the association
between change in prenatal PA and infant birthweight, in grams
Parameter Estimates
Predictors
Primary Exposures
PA Change†
Covariates
Baseline PA*
Maternal Age (y)
Gestational Age (weeks)
Gestational weight gain**
Group Allocation***
Exercise

β

SE

p-value

-0.227

0.234

0.3462

0.017
5.24
156.17
18.31

0.029
12.00
30.32
16.02

0.5512
0.6637
<0.0001
0.2565

-44.46

135.23

0.7431

Note: †Change in PA is represented by individual trajectories (slopes) of PA
across the prenatal period (See Methods section). *Baseline PA is represented by
the intercepts of individual trajectories of PA (See Methods section). **Gestational
weight gain represents weight gain during 17 weeks and 28 weeks of gestation
(corresponding to participant laboratory visits). *** Stretching group is referent.
Physical activity was expressed as steps∙day-1∙month-1.
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Table 3.4. Adjusted linear regression coefficients assessing the modifying
effect of CRF on the association between change in prenatal PA and infant
birthweight, in grams
Parameter Estimates
Predictors
Primary Exposures
PA Change
CRF
CRF*PA change
Covariates
PA Intercept*
Maternal Age (y)
Gestational Age (weeks)
Gestational weight gain**
Group Allocation***
Exercise

β

SE

p-value

-0.98
10.08
0.040

1.01
25.94
0.051

0.3355
0.6987
0.4333

0.023
5.46
152.29
18.22

0.030
12.12
31.01
16.39

0.4473
0.6538
<0.0001
0.2695

-61.75

137.94

0.6556

Note: Change in PA is represented by individual trajectories (slopes) of PA
across the prenatal period (See Methods section). *Baseline PA is represented
by the intercepts of individual trajectories of PA (See Methods section).
**Gestational weight gain represents weight gain during 17 weeks and 28 weeks
of gestation (corresponding to participant laboratory visits). *** Stretching group
is referent. CRF was expressed as ml O2∙kg-1∙min-1. Physical activity was
expressed as steps∙day-1∙month-1.
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CHAPTER 4
OVERALL DISCUSSION
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In the United States, nearly 20% of children and adolescents are classified
as obese(29). Several adverse cardio-metabolic health outcomes are associated
with obesity including type II diabetes and non-alcoholic fatty liver disease(20,
36). Rigorous scientific evidence indicates that participation in sufficient levels of
physical activity may reduce the risk of the development of child obesity(23).
However, child levels of physical activity cannot explain obesity at birth or
infancy. Recent epidemiological evidence indicates that over the past 20 years,
the average birthweight of U.S.-born infants has increased(27). In addition,
increasing trends in infant macrosomia and large-for-gestational age infants are
documented(3, 7, 9). Consequently, heavier neonates have altered grow
trajectories(19), predisposing them to obesity. Because child levels of physical
activity cannot explain obesity at birth or infancy, this suggests that the
development of obesity occurs in utero(17, 31). The prenatal period is the most
critical period for fetal growth and development and is vulnerable to disturbances.
It is well-documented that maternal phenotype (e.g. body mass) and her
behaviors can significantly impact fetal growth(4). Thus, it is important to identify
maternal factors that may affect fetal growth and subsequently infant size.
Considerable evidence indicates that higher levels of maternal physical
activity in the prenatal period protect neonates from overgrowth(35). This
relationship is hypothesized to result from improved maternal metabolic health
thereby controlling the amount of energy suppled to the fetus, resulting in the
development of a healthy-sized neonate(4). This protective effect, however, has
only been demonstrated in normal weight women. Little is known about how
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maternal physical activity might influence infant size in the overweight or obese
population(28, 30, 33). In addition, very few studies have evaluated the
association between maternal cardiorespiratory fitness, an indicator of habitual
physical activity, and neonatal size. The findings of previous studies are
inconsistent with reports of positive, negative and null associations(8, 12, 24).
Moreover, to our knowledge, no studies have assessed this relationship in the
overweight or obese population. The lack of studies among this subgroup is
problematic given the increasing prevalence of obesity in women of reproductive
age(18). Moreover, overweight or obese women are the least active in
pregnancy(22, 32) and are at an increased risk for excessive gestational weight
gain(26), predisposing them to higher rates of delivering macrosomic
neonates(16). Therefore, three studies in this dissertation investigated the
relationships between maternal body mass, physical activity and
cardiorespiratory fitness, prior to and during pregnancy, and infant size.
The purpose of study one was to evaluate the moderating effect of
maternal physical activity in the preconception and prenatal periods on the
relationship between maternal body mass and infant macrosomia. The purpose
of study two was to examine the independent and joint associations between
maternal physical activity, cardiorespiratory fitness and infant birthweight, in a
sample of overweight or obese pregnant women. The purpose of study three was
to describe the relationship between change in maternal PA in the prenatal
period and infant birthweight, in a sample of overweight or obese pregnant
women. In addition, we examined the potential moderating effect of maternal
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cardiorespiratory fitness on the relationship between change in maternal PA and
infant birthweight.
In study one, it was observed that maternal body mass was a significant,
positive predictor of infant macrosomia. Overweight or obese mothers had
increased odds of delivering a macrosomic infant. However, contrary to
hypotheses, neither preconceptual nor prenatal PA moderated the association
between maternal body mass and infant macrosomia. In study two, it was
observed that overweight or obese women led very-low active lifestyles. Maternal
PA from mid-to-late pregnancy was unrelated to infant birthweight. Maternal
cardiorespiratory fitness was also unrelated to infant birthweight in this group. In
addition, maternal cardiorespiratory fitness did not moderate the association
between maternal PA and infant birthweight. In study three, it was observed that,
in overweight or obese women, maternal PA declined from mid-to-late
pregnancy. This decrease in PA was found to be unrelated to infant birthweight.
Overall, this dissertation did not support the hypothesis that maternal PA
prior to or during pregnancy affects the relationship between maternal body mass
and infant macrosomia. In addition, these studies did not find that maternal PA
and cardiorespiratory fitness are related to infant birthweight. Previous evidence
regarding the modifying effect of maternal PA is extremely limited. Only one
study, to our knowledge, has examined this relationship(25) and found that
overweight or obese women reporting little to no PA prior to pregnancy were
more likely to deliver a macrosomic infant. In study two, our null observations
regarding the independent associations of maternal PA and infant birthweight are
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consistent with previous studies among overweight or obese women. However,
these studies conflict with studies conducted among normal weight women which
collectively suggest that maternal PA in pregnancy protects against the delivery
of larger infants(35). Study two also provided unique information about the
relationship between maternal cardiorespiratory fitness and infant birthweight. No
previous studies have assessed this relationship in overweight or obese pregnant
women. The null observation of the association between change in maternal PA
and infant birthweight, found in study three, conflicts with current literature. Clapp
et al. (2002), found that considerable reductions in maternal PA in mid-to-late
pregnancy resulted in the delivery of larger, fatter infants compared to mothers
maintaining or increasing their PA(12). Despite the null findings observed in this
dissertation, these studies contribute to the this rapidly growing area of research,
specifically in the overweight or obese subpopulation.
There are several limitations of this dissertation. For study one, maternal
body mass and physical activity were evaluated using self-reported methods. It is
well-documented that these measures may lead to biased, and less precise
estimated associations(5, 34). These methods are prone to misreporting due to
social desirability(1), the individual’s inability to remember certain behaviors and
the length of the recall period(2). The implementation of objective measures of
maternal body mass and physical activity behaviors, which are demonstrated to
produce more accurate estimates, in future studies are encouraged.
In studies two and three, a small sample size was a significant limitation.
The small sample size in this study may have limited our ability to detect and
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association via a reduction in statistical power. This limitation however, is
common in studies conducted in the pregnant population. Because women
become pregnant sporadically, at any given point in time, the number of women
in the early stages of pregnancy that are available for study recruitment is small.
Thus, recruiting large samples of pregnant women is challenging. Another
limitation to these two studies was the assessment of maternal PA. While
pedometers are an objective measurement tool, they only capture volume of PA.
It is well-documented that other components of PA, including frequency, duration
and intensity, are important to several health parameters(21). Thus, objective
measurements of PA that are able to measure all components of PA, such as
accelerometers, should be used. In addition, we did not consider other potential
health behaviors that have been documented to influence infant size, including
maternal diet(37). Lastly, a limitation across all studies, is the measurement of
infant size. Birthweight is a ubiquitous measure of infant size. However, this
metric fails to provide information on the tissue composition of the infant including
fat and fat-free mass(11). Determining these parameters is important to future
health risks and should be included in future research.
The maternal-child health field is a rapidly growing area of research. While
several studies examining the association between maternal PA and infant size
have been conducted, much remains to be learned about this relationship,
especially in overweight or obese women. Although there is an established
inverse relationship between maternal PA and infant size in normal weight
women(35), the few studies conducted in overweight or obese women have
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reported null associations(28, 30, 33). A lack of a relationship in this subgroup is
problematic given that 50% of women of reproductive age are overweight or
obese(18). Moreover, these women are predisposed to excessive gestational
weight gain(26) and the delivery of larger infants(16). As such, it is imperative
that more research is conducted in this understudied subpopulation. Specifically,
it would be of public health interest to determine a dose of PA that protects
against infant macrosomia. Discovery of such information would be valuable for
exercise prescription guidelines for pregnant women.
Much of the evidence evaluating the relationship between maternal PA
and infant size is epidemiological. This type of research is important to scientific
progress; however, it is only the initial step in describing this relationship. Thus,
our knowledge on the mechanisms that underlie this relationship are largely
unknown. Further, little research has examined the effects of maternal PA on
placental growth and function and its relation to infant size(10, 13). The placenta
is a critical organ as it is the conduit through which the mother and fetus
communicate and regulates fetal energy supply(6, 14, 15). Thus, evaluating the
effects of maternal PA on placental development and function and its relation to
fetal growth is important. Further research into these mechanisms will provide a
more in-depth understanding of the relationship between maternal PA and infant
size.
In summary, the moderating, independent and joint relationships between
maternal PA and CRF and infant size were investigated. Across all three studies,
maternal PA and CRF were unrelated to infant birthweight or macrosomia.
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Similarly, for all three studies, low levels of maternal PA and CRF with restricted
variability were a common explanation for the null findings. Despite the null
observations, these studies contribute important information on these
relationships and serve as an important starting point for this rapidly growing
area of research. Given the paucity of studies investigating these relationships,
specifically in overweight or obese women, more research is warranted. In
closing, these studies did not support the hypotheses that maternal PA or CRF
impact infant size.
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CHAPTER 5
PROPOSAL
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Introduction
In the United States, the prevalence of infants born macrosomic or largefor-gestational age is increasing(114). Evidence suggests that neonates with
excess adiposity at birth may experience altered growth trajectories possibly
attributed to augmented tissue growth during periods of accelerated
development(71, 179, 187) (e.g. adiposity rebound, puberty). Consequently, this
may predispose neonates to obesity(180) and the associated morbidities in
childhood and adolescence.(60, 130)
Maternal size has been identified as a significant predictor of infant size
such that larger mothers produce larger offspring(94, 178). Substantial evidence
has demonstrated that this relationship is potentially a function of nutrient supply.
Nutrient supply has been suggested to be the strongest predictor of fetal growth
as any alterations to the availability of nutrients may have dramatic fetal effects
such as growth restriction or macrosomia(15, 136). In order to optimize fetal
growth, several maternal physiological changes occur, including the onset of
peripheral insulin resistance.(76, 81) However, in pregnancies complicated by
maternal obesity, these changes have been demonstrated to be
exacerbated.(32, 104) In addition, preexisting obesity-related metabolic
consequences including central insulin resistance(51) and poor glycemic and
lipidemic control(90, 145) may result in the availability of excess nutrients in the
intrauterine environment. Given this and the fact that nearly 50% of women of
reproductive age in the U.S. are overweight or obese(63), identifying factors that
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enable pregnant women to control their metabolic intrauterine environment
should be a major public health priority.
Among non-pregnant populations cardiorespiratory fitness and physical
activity have been consistently demonstrated to exhibit protective effects on
several morbidities and mortality.(24, 25, 168) These effects are likely due to the
cardiovascular(49), metabolic(75) and musculoskeletal adaptations(156) that
occur with chronic exercise training that may result in improvements such as
increased insulin sensitivity and improved glycemic and lipidemic control.
Additionally, these effects persist even in the presence of excess adiposity,
suggesting that a “healthy” level of cardiorespiratory fitness and participation in
an adequate amount of physical activity may mitigate the negative effects of
obesity on cardio-metabolic health outcomes.(106, 181) It is reasonable to
suggest that this phenomenon may exist during pregnancy, such that a higher
level of cardiorespiratory fitness and engagement in a sufficient dose of physical
activity at the onset and during the perinatal period may alleviate the adverse
consequences of maternal adiposity on infant birthweight via a controlled
metabolic intrauterine environment. However, to our knowledge, the impact of
cardiorespiratory fitness and/or physical activity on the relationship between
maternal adiposity and infant birthweight is largely unknown.
Statement of the Problem
The major purpose of the proposed study is to determine if participation in
physical activity and/or higher levels of cardiorespiratory fitness in the perinatal
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period alleviate the adverse effects of maternal overweight and obesity on infant
weight status. Specifically, this proposed study will:
1. Determine if maternal physical activity in the preconception and prenatal
period moderates the relationship between maternal weight status and
infant weight status, in a nationally representative and diverse sample of
mothers delivering live-birth infants.

2. Determine if maternal prenatal cardiorespiratory fitness and objectivelymeasured physical activity independently associate with infant weight
status, among a sample of overweight and obese pregnant women.

3. Determine if maternal cardiorespiratory fitness and objectively-measured
physical activity jointly associate with infant weight status, among a
sample of overweight and obese pregnant women.

4. Determine if change in objectively-measured physical activity is
associated with infant weight status, among a sample of overweight and
obese pregnant women.

5. Determine if cardiorespiratory fitness influences the relationship between
change in maternal objectively-measured physical activity and infant
weight status, among a sample of overweight and obese pregnant women.
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Aims
The overarching purpose of this dissertation is to evaluate a developing
hypothesis that higher levels of maternal physical activity and cardiorespiratory
fitness in the preconception and prenatal periods will reduce the negative effects
of maternal weight status on infant weight status.
Aim 1: To observe the potential effect of maternal physical activity during the
preconception and prenatal periods on the association between maternal weight
status and infant weight status, in a representative and diverse sample of women
delivering live-birth infants.
Objective 1A: To determine if self-reported prenatal physical activity
modifies the relationship between maternal pre-pregnancy weight status
and infant weight status.
Objective 1B: To determine if self-reported pre-pregnancy physical activity
alters the moderating effect of prenatal physical activity on the relationship
between maternal pre-pregnant weight status and infant weight status.

Aim 2: To observe the potential effect of maternal cardiorespiratory fitness and
objectively-measured physical activity during pregnancy on infant birthweight, in
a sample of overweight and obese women.
Objective 2A: To determine the effect of cardiorespiratory fitness in midpregnancy on infant birthweight.
Objective 2B: To examine the effect of objectively-measured physical
activity in mid-pregnancy on infant birthweight.
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Objective 2C: To examine the joint effect of cardiorespiratory fitness and
objectively-measured physical activity in mid-pregnancy on infant
birthweight.
Aim 3: To observe the potential effect of changes in maternal physical activity
and cardiorespiratory fitness during pregnancy on infant birthweight, in a sample
of overweight and obese women.
Objective 3A: To evaluate the effect of change in objectively-measured
physical activity from mid- through late pregnancy on infant birthweight.
Objective 3B: To determine if cardiorespiratory fitness in mid-pregnancy
modifies the association between changes in objectively-measured
physical activity from mid- through late pregnancy and infant birthweight.
Scope
Secondary data analyses from one population-based study and one,
randomized controlled exercise intervention trial will be performed to address the
aims and objectives of this proposed study. (1) The National Maternal and Infant
Health Survey sampled resident mothers who had a live birth, fetal death or
infant death in the United States in 1988. Mothers aged 15 years and older,
delivering live-birth infants, who provided data on anthropometrics (i.e. height
and weight) and self-reported physical activity behaviors in the preconception
and perinatal periods will be included in the proposed study. In addition, infants
of these mothers where data on weight status are provided will also be included
in this study. (2) The randomized controlled exercise intervention trial sampled
women in early pregnancy (<14 weeks gestation) whom were at risk for
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preeclampsia (i.e., sedentary, previous preeclamptic pregnancy) from nine
prenatal clinics in one county in the state of Michigan. Pregnant women who had
anthropometry and cardiorespiratory fitness measurements and an objective
measure of physical activity in the perinatal period will be included in this study.
In addition, the infants of these mothers where data on weight status are
available will also be included in this proposed study. The study findings from the
first study will be generalizable to all U.S. mothers aged 15 years and older, who
had live-births in 1988. Generalizations from the second trial will be to all women
at high-risk for preeclampsia that are able to participate in physical activity in the
perinatal period.
Assumptions
The proposed study will make the following assumptions:
1. Pre-pregnancy body mass index is a valid and reliable measure of
maternal adiposity in the preconception period.
2. The mother is able to accurately recall her pre-pregnancy weight and
height after an average period of 17 months postpartum.
3. Self-reported physical activity is a valid and reliable measure of physical
activity behavior in the preconception and perinatal periods.
4. The mother is able to accurately recall her physical activity prior to and
during pregnancy after an average period of 17 months postpartum.
5. Pedometers are a valid and reliable measure of physical activity, and daily
step counts are an accurate measure of daily physical activity behavior.
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6. Last menstrual period and ultrasounds are valid and reliable measures to
estimate gestational age.
7. Data extracted from the birth certificates and medical records are reported
consistently and accurately across all levels (i.e. hospitals, clinics, and
states).
Limitations
Pre-pregnancy body mass index will be calculated based on self-reported
maternal height and weight which rely on the ability of the individual to recall this
information after an extended period of time (~17 months). It has been
demonstrated that women over-report their height and underreport their weight,
and there may be a systematic bias based on their “actual” level of adiposity,
such that larger women may report less accurately.(150) As a result, larger
women may be misclassified into lower body mass index categories. Further,
self-reported physical activity measures are prone to misreporting (over-reporting
or underreporting) due to several reasons (e.g., inability to remember, social
desirability)(4, 161), as such women may be inaccurately categorized as active
which may nullify the potential moderating effect of physical activity on maternal
weight status and infant weight status. One study sampled pregnant women that
were at high-risk for preeclampsia and whom completed a run-in period which
limits the generalizability of these findings to more compliant pregnant women
and may introduce a sampling bias.
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Relevance of the Proposed Study
The proposed study will determine if cardiorespiratory fitness and physical
activity in the preconception and prenatal periods impact the association between
maternal weight status and infant weight status. Consistent evidence has
indicated that maternal weight status is positively associated with infant weight
status.(98, 193) This relationship is suggested to be a function of nutrient supply,
a strong predictor of fetal growth(178). In addition, considerable evidence in nonpregnant populations has demonstrated protective effects of higher levels
cardiorespiratory fitness and physical activity on metabolic health outcomes,
independent of adiposity.(106) Given the potent metabolic effects of physical
activity and exercise,(148) it is of great interest and relevance to determine if
higher levels of cardiorespiratory fitness and physical activity in pregnancy
mitigate the negative impacts of maternal adiposity on infant weight status. The
findings from this study will provide information on whether cardiorespiratory
fitness and/or physical activity are potential strategies that enable a mother to
protect her fetus from overgrowth.
Review of the Literature
Infant Birthweight
Birthweight, defined as the weight in grams at the time an infant is
delivered, has been identified as an indicator of fetal wellbeing and is considered
a strong predictor of infant morbidity and mortality(119, 149). The severity of the
health outcomes associated with birthweight is the most marked at the extremes
of the birthweight distribution (i.e. growth restriction, macrosomia). Infants
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suffering from fetal growth restriction (FGR) or macrosomia are burdened with
increased risk of many immediate and long-term health consequences including
fetal and neonatal death, obesity, type 2 diabetes mellitus and metabolic
syndrome(14, 15, 33, 136). While the suffering of infants born at both birthweight
extremes are of significant public health importance, it appears that the birth of
larger neonates has become a growing concern, particularly among developing
countries.
Trends in Infant Birthweight
Since the 1970s, evidence has suggested upward shifts in the distribution
of infant birthweight among several developing countries. Specifically, Skjaerven
et al. (2000) reported a 100g-increase in mean birthweight over a 30-year period
(1967-1998) in Norway(160). In China, Lu et al. (2011) reported a significant
increase in infant birthweight (+73g) from 1994 to 2005(112), with similar
increases reported in Queensland, Australia from 1988 to 2005
(+1.9g/year)(103), Sweden from 1992 to 2001 (+35g)(169), Canada from 1981 to
1997 (+35g)(182) and in the United States (1985 to 1998)(9). Conversely, in the
United States, some evidence has indicated that mean birthweight declined by
approximately 52g from 1990 to 2005(56). This coincides with a recent report by
Oken (2013) which suggested that mean birthweight continued to decline (as of
2008) since 1990(128). However, birth data from the most recent National Vital
Statistics Report (2013) indicates that from 2006 to 2013 there has been an
upward shift in the birthweight distribution for U.S. infants, suggesting that on
average infants are being born heavier.(114) Specifically, this report indicates
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that the proportion of infants born greater than 3,000g increased from 2006 to
2013 (73.30% to 73.75%, respectively), while the proportion of low birthweight
(i.e. 2,500-2,999g) infants has declined over the same 7-year period (18.44% to
18.22%). Despite some inconsistencies in the scientific literature regarding
trends in infant birthweight over the past several decades, particularly in the
United States, this evidence is suggestive that mean infant birthweight has
increased, and that on average, infants are born heavier.
Although some evidence suggests that, on average, infants are born
heavier, the mean birthweights reported fall within a “normal” range (i.e. 2500 to
4000g) for a “healthy” infant(81). Given this, it is unclear whether the upward
shifts in the birthweight distribution affect the proportion of infants born at the
upper extremes (90th percentile), representing the largest infants. As such, the
use of mean birthweight as a metric to track changes in infant anthropometry,
specifically larger infants, may be inadequate. Birthweight is a crude measure of
infant anthropometry. Consequently, this metric cannot quantify the tissue
composition of an infant. It is generally accepted that a higher birthweight is
indicative of greater adiposity and comparable lean body mass compared to
infants with a normal birthweight(36). However, it is possible that an infant with
an “average or normal” birthweight (2.5 to 3.9 kg), may have significant variations
in tissue composition that cannot be detected with the birthweight metric. Sewell
et al. (2006) demonstrated this concept when comparing birthweights of infants
born to overweight/obese and lean women.(154) These authors reported that
mean birthweight did not significantly differ (3436g vs 3284g, respectively)
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between these groups of women, however, significant differences in percent
body fat (11.6% vs 9.7%, respectively) and fat mass (420g vs 380g, respectively)
of infants were found. Infants born to overweight/obese women had higher levels
of adiposity compared to their lean counterparts, with no differences in lean body
mass. This suggests that birthweight may not be an appropriate measure to
evaluate trends in the prevalence of larger infants, specifically those that may be
more likely to possess an unfavorable tissue composition. As such, to improve
the surveillance of the delivery of larger infants, other metrics may be necessary.
Trends in Macrosomia and Large-for Gestational Age Infants
In the scientific literature, there are two metrics frequently used to describe
a “large” infant. The first metric is macrosomia, which is defined as an infant
weighing 4,000 g (> 4.0 kg) or more at delivery, regardless of gestational age.
The second metric is large-for-gestational age (LGA), which is defined as an
infant born with a birthweight that is at the 90th percentile or higher for a specific
gestational age, compared to a reference population(127). Because these
metrics are specifically used to identify larger infants, it is possible that they may
more accurately capture changes in the proportion of infants born at the upper
extreme of the birthweight distribution.
Similar to the trends in mean infant birthweight, many developing
countries have reported increases in the proportion of infants born macrosomic
and large-for-gestational age. Specifically, in China, Shan et al. (2014)
documented increases in the prevalence of macrosomic infants from 1996 (6.6%)
to 2010 (17.0%)(155). Vranes et al. (2015) reported increases in the proportion of
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infants born macrosomic from 1985 (10.2%) to 2009 (13.6%) in Croatia(177).
Similarly, in Queensland, Australia, there was an increase in the rate of (+0.8%
per year) of macrosomic infants from 1988 to 2005(103). In addition, other
countries including North England (1962 to 2000)(19) and Belgium (1991 to
2010)(73) also reported increases in the prevalence of macrosomia, 25% and
18%, respectively. Trends in the proportion of the delivery of large-for gestational
age infants are similar in that many developing countries have documented
increases in LGA infants. Wen et al. (2003) reported that from 1981 to 1997 there
were significant increases in the proportion of term infants (37-40 weeks) born
LGA in Canada(182). In addition, Ananth et al. (2002) reported increases in term
LGA infants in both Canada from 1985 to 1998.(9) In China, Lu et al. (2011)
reported an increase in LGA infants from 1994 to 2000 (13.72% to 18.98%)(112),
and remained stable through 2005. Moreover, in Sweden, Surkan et al. (2004)
documented a 23% increase in the proportion of LGA infants from 1992 to
2001(169).
Consistent with the conflicting trends in mean birthweight found in the
United States, trends in the prevalence of macrosomia and LGA infants in the US
follow similar patterns. The trends for both these metrics have been reported to
increase, decrease or remain stable over time. For example, Donahue et al.
(2010) reported that the prevalence of infants born LGA declined from 1990 to
2005(56). Extending the previous work of Donahue and colleagues, Oken et al.
(2013)(128) reported that the proportion of infants born LGA decreased in male
and female infants from 1990 (11.1% and 10.5%, respectively) to 2005 (9.4%
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and 9.1%, respectively). Ananth et al. (2002) and Zhang et al. (2010) reported
stable prevalence estimates for LGA infants from 1985 to 1998 and 1992 to
2003, respectively(9, 195). Interestingly, the former study also reported a 25%
reduction in the proportion of infants born macrosomic (2.2% to 1.6%). In
addition, Oken et al. (2013) suggested that the prevalence of macrosomia
declined nearly 50% from 1990 to 2008(128). Conversely, the most recent data
available (2013) from the National Vital Statistics System has documented that
the prevalence of macrosomia in the United States is approximately 8.0%(114).
While this is lower than the prevalence recorded in 1990 (10.88%) by Oken et al.
2013, it is higher than the prevalence rates reported in 2006 (7.82%) and 2008
(7.62%), which may indicate the emergence of an increasing trend in infant
macrosomia. Recent data however, on the trends in the proportion of infants born
LGA, do not appear to be present in the current scientific literature.
Overall, the evidence suggests there are increases in the trends of
macrosomic and LGA infants; however, as with the mean infant birthweight
measure, there are significant limitations to these metrics that may result in the
misestimation of the magnitude of these trends and warrant consideration. First,
there is a lack of consensus in the scientific literature regarding the birthweight
threshold used to define macrosomia. Currently, several thresholds are used
(4000 g, 4500 g, or 5000 g) which may affect not only the direction but the
magnitude of the trends reported. This was demonstrated in the study conducted
by Oken et al. (2013) where macrosomia was defined as a birthweight greater
than 5,000 g and the authors reported a 50% reduction in macrosomia from 1990
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to 2005. The use of a different threshold, such as 4000 g, would have decreased
the magnitude of this reported reduction by 50%, suggesting that macrosomia
only declined roughly 25% during this time period. The incongruity regarding the
birthweight threshold for macrosomia may be in part due to the outcome
associated with a particular threshold. For example, Boulet et al. (2003)
investigated adverse outcomes associated with various birthweight thresholds
that are often used to define macrosomia (i.e. 4000g, 4500g and 5000g)(27). The
authors found that risks of labor complications, birth injuries, and neonatal
morbidity increased with each grade of macrosomia, however only infant
mortality was associated with infants weighing 5000g or more. The authors
suggested that the 4000g-threshold may be best used to predict labor and
neonatal complications, however higher thresholds may be more predictive for
neonatal morbidity (>4500g) and mortality (>5000g).
In addition to lack of consensus on the definition of macrosomia, the
application of a universal threshold for macrosomia across all infants may be
inappropriate. It is well-documented that infant birthweight differs by country,
race, and infant sex. While determining the prevalence of macrosomia across 23
countries, Koyanagi and colleagues (2013) demonstrated the existence of
considerable variability in birthweight among various countries. For example, the
average birthweight was lower in Asian (2697-3181g) and Latin (3119-3311g)
countries compared to the United States (3455g) and China (3369g)(96).
Moreover, it is well-established that male and White infants are born significantly
heavier (~200g) than their female and Black infant counterparts.(7) The latter is
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supported by a recent study by Ye et al. (2014) that reported a significant
increase in risk of adverse perinatal outcomes at different birthweight thresholds
for White (>4500g) and Black (>4300g) infants.(189) Given this, it seems that the
universal application of the 4000 g or greater threshold may be inappropriate.
In addition to the limitations of macrosomia, there are also drawbacks to the use
of the large-for-gestational age metric. First, the LGA measure relies on the
accuracy of the measurement used to estimate gestational age.(17) The most
common method to estimate gestational age is by maternal recall of the first day
of her last menstrual period (LMP). The LMP method is subject to considerable
error. Kramer et al. (1988) demonstrated that despite a positive predictive value
(PPV) of 95% for predicting a term infant, the ability of this method to accurately
estimate gestational age significantly decreased for preterm (PPV=0.775) and
post-term infants (PPV=.119)(97). This is problematic as the inaccuracy of this
method may lead to significant misclassification and misestimation of the
prevalence of LGA infants. Second, the classification of an LGA infant is typically
determined using an established country-specific reference population; however,
many other maternal and fetal factors that have been demonstrated to affect fetal
growth are excluded, including maternal weight, parity, race/ethnicity and infant
sex.(5, 6, 80) In light of this, the use of customized birthweight percentiles to
identify LGA infants have been proposed and studied. For example, Pasupathy
et al. (2012) compared the prevalence rates of LGA and macrosomia using
customized birthweight percentiles, corrected for gestational age, maternal
weight and height, parity, ethnicity and infant sex, to birthweight percentiles of a
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standard reference population.(132) This study found that 53% of macrosomic
and 25% LGA infants, defined using the standard references population, were
misclassified after the adjustment for maternal and fetal characteristics. This
suggests that maternal and fetal factors that have been demonstrated to affect
fetal growth should be accounted for in the identification of larger infants.
Based on the evidence presented, there appears to be increasing trends
in the average birthweight of infants and the proportions of macrosomic and
large-for-gestational age infants in many developing countries including the
United States. Considering the importance of fetal growth to the health and
wellbeing of the infant, the increasing trends in delivery of larger infants, likely
characterized by an unfavorable tissue composition (i.e. increased adiposity),
should be considered a major public health concern.
Maternal-Fetal and Neonatal Consequences to Macrosomia
The increasing trends in excessive fetal growth are problematic as
macrosomia poses numerous and significant health risks to the mother, fetus and
neonate(194). Mothers carrying a macrosomic fetus are at increased risks of
complications during labor (e.g. delayed(158)), delivery (e.g. cesarean
sections(167)) and the postpartum period (e.g. perineal laceration(8),
hemorrhage(163)). Fetuses that are macrosomic may have an elevated risk of
mortality, several morbidities (e.g. asphyxia, congenital anomalies)(93), and
physical injuries incurred during delivery (e.g. shoulder dystocia(82)). Neonates
born macrosomic may be burdened with both immediate (e.g. hypoglycemia,
respiratory distress)(93) and long-term (e.g. overweight/obesity(180), altered
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growth trajectories(101)) health risks. Given this, the development and delivery of
a macrosomic infant is a significant obstetric and public health challenge.
Maternal Environment and Nutrient Supply
While numerous factors have been demonstrated to be related to fetal
growth(115) (e.g., maternal age, parity, race/ethnicity), the strongest predictor
and likely the underlying mechanism between these factors and fetal growth is
nutrient supply to the fetus(74, 178). To ensure that an optimal level of nutrients
is available to the fetus, several physiological adaptations occur throughout the
gestational period(76, 81). Glucose and amino acids are the primary sources of
fuel that are necessary for fetal growth(18). As such, the maternal environment
during pregnancy adjusts to prioritize the availability of these substrates.
Marked physiological alterations to maternal metabolism begin and are
maximized in the 2nd and 3rd trimesters of pregnancy, respectively, concurrent
with the acceleration of fetal growth. The most critical adaptation to the maternal
environment is the development of insulin resistance (IR)(165). This adaptation is
transient as it subsides in the postpartum period and is often referred to as the
“diabetogenic” state of pregnancy. The onset of IR occurs in the 2nd trimester and
progressively worsens through the middle of the 3rd trimester. The IR
predominantly affects the periphery (e.g. skeletal muscle) with reported
reductions in insulin sensitivity between 55 to 70%(37). The primary purpose of
the development of IR is to reduce maternal uptake and utilization of glucose and
amino acids in an effort to spare these substrates for the fetus(131, 164). To
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satisfy the metabolic needs of the mother, catabolism of the maternal fat stores
deposited in early pregnancy increases dramatically(95).
The presence and severity of IR in pregnancy is most evident in the basal
and postprandial periods. In the basal state, consistent evidence indicates that
levels of glucose and amino acids are lower compared to non-pregnant women
suggesting enhanced fetal uptake of these substrates(66). This phenomenon is
often referred to as “accelerated starvation.” Also during this state, maternal
levels of free fatty acids are significantly elevated compared to non-pregnant
counterparts(95). In addition, insulin levels are also elevated and are higher
compared to non-pregnant women. Despite higher levels of insulin, hepatic
glucose production is increased (16 to 30%(38)) in the fasting state, likely as an
attempt to increase the amount of glucose available to the fetus. Because insulin
inhibits the mobilization of glucose, the increased levels of hepatic glucose
production may be suggestive of slight central insulin resistance(52).
In the postprandial period, several exaggerated metabolic responses
occur. First, the glucose levels increase significantly to a higher peak and are
sustained for a prolonged period in pregnant women compared to non-pregnant
women, due to the presence of insulin resistance. Second, in order to
compensate for the sustained hyperglycemia, the insulin response is augmented
by 200 to 250%(31, 34). In an effort to overcome the hyperglycemia found in the
postprandial period the significant increase in insulin levels is suggested to help
“push” the nutrients (i.e. glucose and amino acids) to the uteroplacental unit for
fetal uptake and is referred to as “facilitated anabolism(67).” Failure of the
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pancreatic β cells to adequately compensate to the elevated glucose levels often
results the diagnosis of gestational diabetes mellitus(28).
Given the importance of nutrient supply to optimal fetal growth and
development, the maternal metabolic environment adjusts to ensure adequate
availability of nutrients. Disturbances in the maternal environment that may affect
nutrient supply may have adverse effects on fetal growth. These disruptions often
result in fetal growth restriction or fetal overgrowth, each possessing immediate
and long-term effects on the health of the progeny.
Nutrient Supply and Fetal Overgrowth
In the scientific literature, disruptions in nutrient supply often result in
reduced or excessive fetal growth(14, 136). Given the current rise in the delivery
of macrosomic and LGA infants occurring in the U.S., disturbances that lead to
excess nutrient availability are of particular interest. The most demonstrable
example of the effects of excess nutrient supply is found among women with
pregnancies complicated by diabetes.
Over a half century ago, while working with women diabetic pregnancies,
Jorgen Pedersen formulated the hyperglycemic-hyperinsulinemic model,
commonly known as the Pedersen Hypothesis(134, 135). This hypothesis
suggests that fetal overgrowth was due to repeated exposure of higher levels of
maternal glucose (i.e. hyperglycemia) during pregnancy. In addition, Pedersen
speculated that the excessive glucose transferred to the fetus induced fetal
hyperinsulinemia. Because maternal insulin cannot cross the placenta(122), it
was hypothesized that in response to hyperglycemia, the fetal pancreas secreted
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heightened levels of insulin. This is supported by evidence demonstrating
enhanced fetal pancreatic growth via increased β cell mass and function (i.e.
insulin content and secretion) found among fetuses of diabetic mothers.(142,
192) Augmented levels of insulin are suggested to further stimulate the release of
growth-promoting factors (e.g. insulin-like growth factors) subsequently
increasing adipocyte deposition in the fetus(65). In support of this, studies have
found higher levels of c-peptide, a marker of insulin secretion, and growth factors
in macrosomic infants compared to normal weight infants(13).
While diabetic pregnancies (e.g. type I, II and gestational) are associated
with the highest risk of delivering a macrosomic infant, only 14% of pregnancies
are complicated by diabetes(83). This suggests that diabetic pregnancies are
likely not a significant contributor to the increasing trend in the delivery of
macrosomic and LGA(58). This may suggest that other maternal factors
exhibiting similar perturbations on the intrauterine environment (i.e.
hyperglycemia) may be a more plausible explanation. Interestingly, a common
co-morbidity of women with diabetic pregnancies is the presence of overweight
or obesity. Evidence has indicated that nearly 70% of women with gestational
diabetes are overweight of obese(89). Accumulating evidence suggests that
maternal pre-pregnancy obesity is a significant, independent risk factor for the
delivery of a macrosomic infant(23, 69). In addition, a recent epidemiological
surveillance study indicated that nearly half (46%) of women of reproductive age
(20 to 39 years) are overweight or obese, with evidence of an increasing
trend(63). Given this and evidence supporting maternal body mass as an
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independent risk factor for augmented fetal growth, it is plausible that maternal
overweight and obesity may be the dominating factor explaining the rise in infant
macrosomia.
Maternal Obesity and Fetal Growth
Consistent evidence has demonstrated that maternal size is a significant
predictor of fetal size, such that larger mothers produce, on average, larger
offspring(74, 178). This relationship is suggested to exist as a function of nutrient
supply, whereby larger mothers deliver more nutrients to their fetus compared to
their smaller counterparts; potentially due to the augmented amount of maternal
energy resources and disruption of the metabolic environment(110, 145).
Evidence suggests that the mechanisms that underlie the relationship between
maternal obesity and infant macrosomia are similar to the hyperglycemichyperinsulinemic model in the Pedersen hypothesis.(133, 136) Specifically, some
studies have indicated that obese mothers may enter the perinatal period with
existing metabolic dysfunction (e.g. insulin resistance) which may exacerbate the
normal physiological adaptations that occur throughout pregnancy.(90)
Consequently, it is the augmentations of these changes that are suspected to
result in increased nutrient availability to the fetus and subsequently enhance
fetal growth.
The exacerbations of the pregnancy-induced changes to maternal
metabolism are most evident when fetal growth is accelerating. As previously
described, the onset of peripheral insulin resistance begins in the second
trimester, primarily affecting maternal peripheral glucose uptake. Compared to
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non-obese pregnant women, obese pregnant women are suggested to present
with pronounced insulin resistance, higher levels of glucose, amino acids, and
free fatty acids in the fasting and postprandial periods.(90) Maternal insulin levels
are substantially increased (~130%)(34). Despite this, the actual insulin response
to a glucose stimulus is reduced compared to non-obese pregnant women (~200250%)(31), suggesting a potential pancreatic β cell impairment. Further, the
suppression of hepatic glucose production via increased insulin levels has been
demonstrated to be delayed up to four hours in obese pregnant women which
suggests a greater level of central insulin resistance compared to non-obese
pregnant women(159). Collectively, these findings indicate that the exaggerated
metabolic adaptations in pregnancy found among obese pregnant women may
result in a “hypernutrient” intrauterine environment in which the fetus is exposed
to prolonged periods of excess nutrient availability. Similar to the Pedersen
Hypothesis, the fetal consequences of exposure to excess nutrients in the
intrauterine environment include increased adipocyte deposition, altered
pancreatic growth and function, and organomegaly(65, 166, 170). In addition,
recent evidence has also demonstrated that infants born to obese mothers may
have early signs of metabolic syndrome(35).
Considering that nearly half of women of reproductive age are overweight
and obese(63), it is plausible that pre-pregnancy overweight and obesity is the
dominating force behind the increasing trends in infant birthweight and
prevalence of macrosomic infants. Consistent evidence has demonstrated that
maternal overweight and obesity exacerbates the normal physiological

123

adaptations to maternal metabolism occurring throughout gestation potentially
resulting in excess nutrient availability to the fetus. The repeated exposure to the
maternal metabolic dysfunction in the intrauterine environment may have
significant adverse consequences to fetal growth and development, specifically
increased adiposity at birth and risk of poor metabolic health outcomes in the
future(105).
Maternal Resources Hypothesis
The substantial body of evidence underlying the Pedersen hypothesis has
provided significant insight to the etiology of infant macrosomia, especially in
pregnancies complicated by diabetes. More recent evidence however, has
indicated that diabetes need not be present in the gestational period for
metabolic perturbations to exist in the intrauterine environment.(32) While it
suggested that maternal overweight and obesity may play a more significant role
in explaining the increasing trends in larger infants(58), a majority of overweight
and obese women do not give birth to macrosomic or large-for-gestational age
neonates. In fact, a recent meta-analysis evaluating the relationship of maternal
obesity on the occurrence of fetal macrosomia found that while the odds of
delivering a large-for-gestational age or macrosomic infant (>4000g or >4500g)
are increased among obese mothers, only 22.4%, 15.3%, and 3.9% of obese
mothers delivered overgrown fetuses, respectively(70). Additionally, 50% of the
macrosomic infants in the sample were born to normal weight mothers, and the
remaining 50% to overweight and obese mothers. This potentially suggests that
other factors may be more influential on fetal growth.
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While the evidence to support the adverse influence of maternal weight
status on fetal growth is significant, it fails to consider and explain one critical
factor that has been demonstrated to have potent effects on human metabolism,
that is, physical activity. Until recently, the potential important impact of maternal
physical activity on the intrauterine environment and fetal growth has been
mostly ignored. The maternal resources hypothesis is a recently developed
theory that extends upon the current hypotheses on the influence of the
intrauterine environment, with regard to nutrient supply, and fetal growth. The
maternal resources hypothesis attempts to explain how maternal phenotype,
specifically maternal body composition (i.e. obesity) and behavior (i.e. physical
activity) impact the intrauterine environment and subsequently, the development
of the fetus(10).
Physical Activity and Nutrient Supply
During pregnancy, maternal and fetal tissues compete for nutrients.
Competition in early pregnancy is low as fetal energy demand is minimal. As
pregnancy progresses coincident with accelerated fetal growth, the competition
for nutrients increases dramatically. Alterations to the maternal environment in
pregnancy (e.g. IR) are orchestrated in a manner to tightly control the
competition for nutrients such that adequate levels of nutrients are available to
both the mother and fetus. Additionally, maternal behaviors may also change in
order to maintain a balanced competition for nutrients such as increases caloric
intake (~200-300 kcal per day) and/or reductions in physical activity(91, 92).
However, severe changes in these compensatory maternal behaviors,
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specifically physical activity, may create an imbalance in the nutrients available to
the maternal and fetal tissues thereby adversely affecting fetal growth. For
example, higher levels of energy expenditure akin to hard physical labor may
result in maternal tissues out-competing the fetus for nutrients and consequently
restricting fetal growth. Such an extreme level of physical activity is often found
among pregnant women in developing countries(172). Conversely, significant
decrements in maternal physical activity may decrease the competition for
nutrients between maternal and fetal tissues such that excess nutrients are
supplied to the fetus. This extreme is likely what is characteristic of maternal
physical activity behavior in the United States. This is evidenced by significant
decrements in physical activity with advancing gestation, reports of pregnant
women spending nearly 50% of their day in sedentary behaviors and less than
25% of pregnant women achieving the daily 30-minute physical activity
recommendation set forth by the American Congress of Obstetricians and
Gynecologists (ACOG) and Physical Activity Guidelines for Americans(12, 61,
62).
Impact of Physical Inactivity on Metabolic Control and Fetal Growth
The maternal resources hypothesis posits that maternal physical inactivity
is the primary determinant to the excess nutrient availability in the intrauterine
environment as a result of metabolic dysfunction. In support of this hypothesis, it
is well established that skeletal muscle tissue accounts for 40% of body mass
and nearly 80% of insulin-mediated glucose uptake(16) and as such, is a major
determinant of whole-body glucose and lipid homeostasis(2). Consequently, any
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disturbances to this function may have adverse metabolic effects to the maternal
and fetal environment.
In non-pregnant populations, considerable evidence has demonstrated
that physical inactivity is associated with significant reductions glycemic
control(21). Specifically, decreased energy expenditure is suggested to induce
decrements in peripheral insulin sensitivity, glucose uptake and oxidation via
disruption of the insulin signaling pathways(68). Additionally, excess glucose in
the muscle is converted to lipids via de novo lipogenesis thereby increasing lipid
accumulation in muscle(20). Elevated levels of intramuscular lipids are also
proposed to inhibit insulin signaling, therefore may play a role in peripheral
IR(138). Collectively, these alterations in the energy flux of the skeletal muscle
may induce hyperglycemia.
Decreased levels of physical activity are also suggested to adversely
affect lipidemic control(88). Evidence indicates that physical inactivity
downregulates lipoprotein lipase (LPL) activity, a key enzyme in the regulation of
free fatty acid uptake in skeletal muscle, resulting in elevated blood lipid levels. In
addition, free fatty acid oxidation in skeletal muscle is also reduced and available
fatty acids are suggested to be diverted to storage, further perpetuating the loss
in lipidemic control. Moreover, hyperlipidemia, in addition to hyperglycemia is
also hypothesized to increase de novo lipogenesis in the liver and adipose
tissue, further elevating blood lipid levels. Consequently, it appears that the
presence of hyperglycemia and hyperlipidemia are initiated by physical inactivity
and are augmented by each other’s presence(26, 87).
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While a substantial proportion of the evidence supporting the adverse
metabolic effects of physical inactivity has been demonstrated among nonpregnant populations and pregnant animal models, these mechanisms are
suggested to occur similarly in pregnant humans. The maternal resources
hypothesis hypothesizes that the metabolic consequences of the low levels of
physical activity and high levels of sedentary behavior(61, 62) found among
pregnant women may augment the existing pregnancy-induced metabolic
adaptations (e.g. IR). Specifically, low levels of physical activity may worsen
peripheral insulin resistance thereby exacerbating hyperglycemia and
hyperlipidemia, especially in the postprandial periods(121) and thus, increasing
the maternal-fetal glucose and lipid concentration gradient favoring the diffusion
of these nutrients across the placenta and creating a ‘hypernutrient’ environment
for the fetus(48, 77).
The fetal consequences to the repeated exposure to a ‘hypernutrient’
environment proposed in the maternal resources hypothesis reflect those found
in the Pederson Hypothesis. Excess nutrient availability in the intrauterine
environment is suggested to induce fetal hyperinsulinemia via a heightened
insulin response of the fetal pancreas(166). As demonstrated, the pancreases of
fetuses grown in hyperglycemic environment are shown to have increased mass
and function126. The fetal hyperinsulinemic environment has been demonstrated
to augment the presence of growth factors which may contribute to adipocyte
hyperplasia(65, 86) (i.e. more adipocytes). In addition, the maternal resources
hypothesis posits that excess nutrient availability has been suggested to
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exacerbate fetal adipogenesis via increased number of free fatty acids and
glucose transporters, uptake of free fatty acids into fetal adipocytes and
triglyceride storage in addition to elevated enzymes that have been suggested to
stimulate de novo lipogenesis in fetal adipose tissue(57, 110).
Another unique contribution of the maternal resources hypothesis is the
suggestion the excess nutrient availability induced by maternal physical inactivity
may also alter fetal skeletal muscle development and function. Skeletal muscle
development is nearly complete by the second trimester of pregnancy suggesting
that any disruptions in early pregnancy may have a significant and permanent
impact on the function of fetal skeletal muscle tissue129. Some evidence indicates
that maternal metabolic dysfunction has been demonstrated to be associated the
reduction in the size of muscle fibers and increased collagen accumulation within
fetal skeletal muscle tissue(113). Smaller muscle fibers and accretion of fibrous
tissue may impair the ability of muscle to generate force and overall function of
skeletal muscle.
The negative effects of physical inactivity on maternal metabolic health
posited in the maternal resources hypothesis may be of particular concern for
overweight and obese pregnant women. In non-pregnant and pregnant
populations, overweight and obese women have been demonstrated to be the
least active subgroup(50). Low levels of physical activity in the preconception
period may increase the risk of a woman entering pregnancy with existing
metabolic dysfunction (e.g., insulin resistance, poor glycemic/lipidemic
control)(21, 68). This is problematic given that the development of the fetal
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pancreas occurs early in pregnancy(139). As previously described, poor
metabolic health may increase nutrient availability and alter the development and
function of the growing fetal pancreas, specifically the β-cells. Moreover,
evidence has indicated overweight and obese pregnant are at an increased risk
of gaining excessive weight during pregnancy(53, 55, 79). In fact, nearly 60% of
this subpopulation exceed the weight gain guidelines put forth by the Institute of
Medicine(188). Substantial evidence in the scientific literature has demonstrated
that excessive gestational weight gain is fairly strongly associated with the
delivery of a larger infant. Given the established positive relationship between
body weight and energy expenditure(108), it is reasonable to suggest that the
augmented levels of weight gained found among overweight and obese pregnant
women may be a result of decreased levels of physical activity. That is, the
heightened level of energy expenditure of a larger pregnant woman that is
required for a given activity may reduce physical activity. Consequently, there are
adverse maternal and fetal effects to the decrements in this behavior and weight
gain. First, as previously discussed, physical inactivity has negative effects on
metabolic health. The associated poor glycemic and lipidemic control affects both
the mother and her fetus due to increments in the availability of nutrients. For the
mother, the excess nutrients may be partitioned to her fat stores thereby
increasing fat deposition and weight gain(29). Unfortunately, this unnecessary
gain in weight may perpetuate further reductions in physical activity potentially
augmenting metabolic dysfunction and promoting excessive weight gain. For the
fetus, the metabolic dysfunction as a direct and indirect consequence of physical
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inactivity and weight gain, respectively, may lead to increased placental transfer
of nutrients(48, 77) and subsequently enhance fetal growth via altered growth
and function of the fetal pancreatic β-cells(166) and consequent adipocyte
deposition(86).
Collectively, the maternal resources hypothesis hypothesizes that the
disturbances to nutrient supply, the strongest predictor of fetal growth, are a
result of reduced levels of physical activity that likely occur in the preconception
and perinatal periods. Physical inactivity during gestation is suggested to perturb
the metabolic intrauterine environment via considerable decrements in skeletal
muscle tissue energy demand and augmentation of the pregnancy-induced
insulin resistance resulting in poor glycemic and lipidemic control. Subsequently,
excess nutrients are provided to the fetus thereby altering fetal pancreatic β cell
mass and function, inducing fetal hyperinsulinemia and promoting hypertrophy
and hyperplasia of adipocytes and altered fetal skeletal muscle development.
Consequently, the effects of the exposure to metabolic insults in pregnancy
potentially result in a metabolically compromised, heavier, fattier neonate with
less functional skeletal muscle tissue and a predisposition to adverse cardiometabolic health outcomes as a child, adolescent and adult (e.g. obesity, type II
diabetes).
Physical Activity or Exercise and Fetal Growth
According to the maternal resources hypothesis, the low levels of physical
activity in the perinatal period are suggested to be the primary mechanism for the
increasing trends in infant macrosomia and LGA infants. As such, it seems
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reasonable to speculate that the participation in adequate levels of physical
activity or exercise in pregnancy may improve glycemic and lipidemic control,
thereby controlling nutrient supply and protecting against fetal overgrowth.
Among pregnant populations, several studies have examined the impact of
physical activity or exercise on fetal growth(183). Although physical activity and
exercise are related, differences in their influence on health outcomes exist(72,
184). Physical activity is defined as any movement produced by the skeletal
muscles that elicit levels of energy expenditure above that equivalent to resting.
While exercise falls under the overarching definition of physical activity, exercise
is defined as a type of physical activity that is structured, repetitive and goaloriented with the purpose of improving or maintaining physical fitness(30). Given
the differences in these terms, it may be anticipated that the evidence regarding
their respective effects on fetal growth may differ and as such, they will be
reported separately.
Physical Activity in Pregnancy and Fetal Growth
Evidence from studies evaluating the impact of physical activity in
pregnancy on fetal growth is equivocal. A recent study from Mudd and
colleagues (2014) reviewed studies examining the relationship between leisure
time physical activity (LTPA) on several maternal and fetal outcomes including
fetal growth. The study found that, in general, LTPA was inversely associated
with the delivery of a macrosomic or LGA infant and importantly, no increase in
risk for the delivery of a small-for-gestational age (SGA) infant(124). These
findings are in conflict with another review by Takito et al. (2009), which reviewed
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studies assessing the impact of maternal physical activity on neonatal outcomes,
inclusive of infant weight status. This study found that women engaging in lower
intensity physical activity were associated with increases in infant birthweight
whereas participation in vigorous activities was associated with decrements in
infant birthweight(173). These associations were only significant in the third
trimester of pregnancy, likely due to the increased fetal energy demand.
Interestingly, the association found between vigorous physical activity and infant
birthweight varied by activity status of the mother. These authors found that
active women reporting participation in vigorous activity in pregnancy was
protective against the delivery of a low birthweight infant, however for sedentary
women, engaging in vigorous activity in pregnancy increased the risk of a low
birthweight infant. The latter finding may be due to the combination of the
unaccustomed stress of high intensity activity and the stress from pregnancyrelated changes, which may result in a compensatory augmented uptake(175) of
nutrients (e.g. glucose) and an abnormal reduction in the nutrients available to
the fetus. The former finding is supported by a controlled trial conducted among
elite athletes in pregnancy(84). In this study, pregnant athletes were assigned to
a moderate or vigorous exercise training regimen. The authors reported
increased birthweights among the high intensity group compared to the moderate
intensity group.
Studies evaluating the impact of objectively-measured physical activity on
fetal growth did not provide any clearer insight on this relationship. Rufriok et al.
2014 performed a secondary data analysis using data from two randomized
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controlled trials(151). Physical activity was assessed at 15 weeks and between
32 to 35 weeks of gestation using an Actigraph accelerometer. These authors
found that participation in moderate-to-vigorous physical activity or sedentary
behavior had no effect on infant birthweight. Similarly, in a prospective cohort
study, Morgan and colleagues (2014) found that physical activity was not
associated with the delivery of a macrosomic infant(123). Conversely, in a
prospective cohort study, Reid et al. (2014) compared the free-living physical
activity and sedentary behaviors, via SenseWear Armband, of women predicted
to deliver macrosomic infants relative to controls(146). This study reported that
women predicted to deliver a macrosomic infant engaged in less physical activity
and more sedentary behavior compared to women predicted to deliver nonmacrosomic infants.
Based on the findings from these studies, it appears that the impact of
physical activity on infant weight status is inconclusive. Several factors may
account for the equivocal nature of the evidence of this relationship. First, a
majority of studies examining the association between physical activity and fetal
growth utilize self-report measures (e.g., questionnaires, interviews) which vary
considerably in the questions used to quantify physical activity and the time
period for recall of this behavior (e.g. 1 year, 3 months). Moreover, self-reporting
methods are notorious for providing inaccurate estimates of physical activity
behavior given issues with recall, social desirability etc(4, 161). Further, the
timing of the measurements may have also influenced the findings (e.g. early,
mid or late pregnancy). While objective measures of physical activity have been
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demonstrated to provide more accurate estimates of physical activity, many of
the cut-point thresholds used in these studies were derived from studies
conducted among non-pregnant populations(111). Considering substantial
physiological changes occur in pregnancy including increases in resting energy
expenditure(3, 143), it is reasonable to suggest that the intensity threshold
between pregnant and non-pregnant populations are dissimilar. Lastly, the
ambiguity of this relationship could be due to the variability in the metric used to
define infant weight status. Among these studies, various weight status metrics
used included infant birthweight, large-for-gestational age (>90th percentile),
macrosomia (e.g., >4000g, 4500, or >5,000g). Based on the mixed results and
limitations of these studies, it appears that the evidence regarding the effect of
maternal physical activity in pregnancy on infant weight status is inconclusive.
Exercise in Pregnancy and Fetal Growth
Given that exercise is structured, repetitive, and progressive in nature(30)
it is plausible that exposure to this type of physical activity may exhibit stronger
effects on fetal growth. Additionally, compared to the studies assessing freeliving physical activity, exercise training studies likely employ more rigorous study
designs and methodologies (i.e. randomized controlled trials, supervised) which
may provide better insight nature of the relationship between exercise and fetal
growth.
Recently, Wiebe et al. (2015) conducted a systematic review of
randomized controlled and controlled trials that examined the effects of
supervised prenatal exercise on fetal growth(183). The authors of this review
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reported that, in general, women participating in supervised exercise programs
during the perinatal period had lower odds (31%) of delivering a macrosomic or
large-for-gestational age infant. Additionally, reductions in mean infant
birthweight were found among infants born to mothers who exercised during
pregnancy compared to infants born to non-exercising mothers. Interestingly, this
significant finding was restricted to studies conducted among normal weight
women (n=26). The three studies implemented among overweight and obese
pregnant women found that participation in an exercise program did not elicit any
effect on infant birthweight or the delivery of a macrosomic or large-forgestational age infant. The lack of a significant effect of exercise on infant weight
status among overweight and obese pregnant women is similar to the findings of
another review assessing the effects of exercise on gestational weight gain.
McDonald et al. (2016) examined the effects of exercise interventions on
gestational weight gain and found that 75% of interventions that found a
statistically significant reduction in weight gain were conducted among normal
weight women(117). Considerable evidence has demonstrated a positive
relationship between body weight and energy expenditure(11, 108). This
suggests that there is increased difficulty with movement among heavier
individuals, which may explain why overweight and obese women are the least
active in the pregnant population and tend to have the worst compliance to
exercise interventions. Lower compliance found among these women likely
results in a reduced exercise dose and as such, may be insufficient to impact
infant size.
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Conversely, Leet & Flick (2003) conducted a meta-analysis on 30
randomized controlled, controlled trials, and prospective cohort studies
evaluating the effects of prenatal exercise on fetal growth(107). Overall, this
review found that maternal exercise does not have an appreciable effect on
mean infant birthweight. However, among mothers who continued vigorous
exercise into the 3rd trimester, significant reduction in birthweight (200 to 400g)
were found compared to active controls. Interestingly, this reduction in
birthweight only applied to women engaging in endurance activity during
pregnancy. Participation in non-endurance exercise in the perinatal period did not
exhibit any effect on infant birthweight. A recent review evaluated the impact of
various types of exercise training (i.e. aerobic, resistance and combined) on
maternal and infant health, inclusive of infant weight status. Perales and
colleagues (2016) found that for aerobic exercise training studies, reductions in
birthweight were found(137). Among resistance exercise training studies, too few
studies assessed the effects on infant weight status for the authors to draw any
conclusions. Studies exposing pregnant women to both aerobic and resistance
training found decreased risk in the delivery of macrosomic infants and
reductions in infant birthweight. However, these findings represent only 3 of 21
studies evaluating this relationship, with the remainder reporting no effect on
infant weight status.
The conflicting findings regarding the effects of physical activity and
exercise on fetal growth may be due to the influence of factors related to the
exercise regimen prescribed including, volume and type, timing in pregnancy
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(e.g. trimesters), and pre-pregnancy activity of the mother. Clapp and colleagues
demonstrated the impact of some of these exercise-related factors in a series of
prospective controlled trials implemented in the perinatal period(41, 42, 46).
Clapp et al. (2002) examined the effect of exercise volume in pregnancy on fetal
growth among a group of active women(42). This study found that pregnant
women that maintain or increase their exercise volume ≥ 50% of preconception
levels in mid- to late pregnancy, on average, deliver lighter (3390g vs 3810g) and
leaner (8.3% vs 12.1%) infants compared to women who decrease their exercise
below this level in similar trimesters. Interestingly, in another study, Clapp &
Capeless (1990) compared the effects of two types of endurance exercise
(running vs dance aerobics) on birthweight in a sample of active pregnant
women(40). Compared to active (pre-pregnancy) controls, women engaging in
either types of endurance exercise throughout pregnancy delivered lighter
(3381g vs 3691g) and leaner (11.2% vs 16.1%) infants. The birthweights and/or
anthropometrics of infants did not differ between the two endurance groups.
Conversely, Clapp (2003) speculated that the effect of exercise type on fetal
growth may be found when comparing weight-bearing to non-weight bearing
exercise(44). Similar controlled studies conducted among active women in
pregnancy who were exposed to non-weight bearing exercise (e.g. cycling) found
that this type of exercise did not have an effect on birthweight(47). The difference
in the effect of these types of exercises on fetal growth may be due to the level of
energy expenditure that is associated with each type(102). Consistent evidence
has demonstrated that weight-bearing exercise elicits greater levels of energy
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expenditure compared to non-weight-bearing exercise. This suggests that the
former may reflect a higher intensity of exercise and may explain the reduction in
birthweight associated with this type of exercise.
Findings from another study by Clapp et al. (2000) suggest that the effect
of exercise on fetal growth may differ based on the activity status of the mother in
the preconception period(41). In this study, non-active women were randomized
to an exercise condition or control at eight weeks of gestation. Contrary to the
findings reported by Clapp et al. (1990, 2002) among active women, the findings
from this study demonstrated a positive effect of exercise on birthweight.
Previously inactive women that initiated an exercise regimen in pregnancy were
found to have heavier infants (3660g vs 3430g) compared to sedentary controls.
Body composition (e.g. lean and fat mass) however, was similar between the
groups. These findings are in contrast with the meta-analysis of controlled trials
conducted by Wiebe et al 2015 and with a large prospective cohort study in
Norwegian pregnant women, which found that women reporting an inactive
lifestyle in the preconception period delivered lighter infants and were less likely
to deliver a macrosomic infant(99). In another study however, Löf et al. (2008)
found that pre-pregnancy physical activity was not associated with infant
birthweight(109).
Taken together, it appears that the evidence regarding the effects of
physical activity and exercise on fetal growth is suggestive of an inverse
relationship, such that mothers continuing or initiating exercise in pregnancy may
be associated with reduced infant birthweight or decreased risk of delivering a
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macrosomic or LGA infant. In addition, it appears that the effect of exercise on
fetal growth may vary depending on the exercise-related (e.g. volume) and
maternal (e.g. body mass index, activity level) factors. Further, the evidence for
this relationship is very limited for overweight and obese women. This is likely
due to several factors, which may include small number of exercise trials, low
activity levels among this subgroup(50), which likely increases the difficulty of
participant recruitment, and this subgroup are often the least compliant(117),
which may result in poor adherence to the exercise protocol and potentially
diminished effects. The lack of evidence is unfortunate as nearly 50% of women
in the preconception period are overweight or obese. Given the considerable
evidence demonstrating a positive relationship between maternal adiposity on
fetal growth(69, 90), determining whether exercise may be a useful strategy for
alleviating the negative effects of maternal weight status on infant weight status
should be a public health priority.
Cardiorespiratory Fitness in Pregnancy and Fetal Growth
Cardiorespiratory fitness is defined(171) as the “ability to engage in
physical activities that rely on oxygen consumption as the primary source of
energy…and the body’s ability to transport and utilize oxygen.” Among diverse
non-pregnant populations, cardiorespiratory fitness has been demonstrated to be
inversely associated with several cardio-metabolic morbidities(118, 168) and
mortality(25, 106). Because cardiorespiratory fitness is an attribute of an
individual, the mechanisms that underlie its relationship with many cardiometabolic health outcomes are likely due to the cardiovascular(49),
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musculoskeletal(75), and metabolic(156) adaptations that occur as a result of
chronic exercise training. As such, higher levels of cardiorespiratory fitness have
been demonstrated to be positively associated with metabolic health,
characterized by improved glycemic(162) and lipidemic(147) control, insulin
sensitivity(120) etc. As indicated in the maternal resources hypothesis, poorer
metabolic health in pregnancy as a result of low physical activity, has been
suggested to be the primary mechanism that leads to fetal overgrowth. Based on
the evidence among non-pregnant populations regarding the relationship
between cardiorespiratory fitness and metabolic health, it seems reasonable to
speculate that pregnant women possessing a higher level of fitness may 1)
demonstrate better metabolic health and 2) deliver infants with reduced
birthweights compared to their lower fit counterparts.
Cardiorespiratory Fitness in Pregnancy
Several studies have assessed cardiorespiratory fitness in the perinatal
period; however much of this literature has focused on three areas 1) changes in
cardiorespiratory fitness with advancing gestation, 2) improvements in
cardiorespiratory fitness in response to exposure to exercise training, and 3)
responses to exercise, submaximal and maximal fitness testing among active
and inactive women.
Although there appears to be inconsistency in the scientific literature
regarding the changes in cardiorespiratory fitness with advancing gestation, there
is a suggestion that cardiorespiratory fitness is maintained(39, 54, 59, 100, 116,
174). In support of this idea, well-documented maternal physiological adaptations
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that occur in pregnancy mimic those achieved by chronic exercise training
including increased cardiac output, blood and plasma volume, hematocrit and
hemoglobin and decreases in systemic vascular resistance(45, 81). There are
two primary purposes to these adaptations. First, these maternal changes ensure
that there is adequate blood flow to deliver oxygen and nutrients to the
uteroplacental unit and fetus. Second, these alterations also make certain that
the mother’s normal physiological function is not comprised thereby enabling her
to continue usual activities in pregnancy. From an evolutionary perspective, if
cardiorespiratory fitness were to decline, this may limit the mother from carrying
out necessary tasks (e.g. activities of daily living) potentially reducing metabolic
health and imposing adverse effects on the fetus. Additionally, reduced
cardiorespiratory fitness may also be disadvantageous during labor and delivery
as well as in the early postpartum period, all of which consist of energy
demanding tasks (e.g., birth, childcare).
Nonetheless, the ambiguity present in the literature regarding this
relationship may be due to several factors. First, the cardiorespiratory fitness
testing procedures differ considerably between studies including the mode of
exercise (cycle versus treadmill), type of fitness testing (submaximal versus
maximal), and equations used to estimate maximal oxygen consumption, which
are often validated in non-pregnant populations. Second, significant individual
variability exists among these studies which may in part be inherent in nature, but
also may be due to the use of small sample sizes. Third, many studies use nonpregnant or postpartum controls to assess changes in cardiorespiratory fitness.
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This is problematic as 1) the control subjects used are not the same individual
being tested, despite matching on demographic variables, and 2) with respect to
postpartum controls, the timeframe in which pregnancy related changes (e.g.,
cardiac output, blood volume) are normalized is uncertain and varies
considerably (e.g. 2 weeks to 52 weeks). Lastly, a considerable majority of the
studies assessing cardiorespiratory fitness across pregnancy are conducted
among healthy, normal weight pregnant women, which severely limits the
generalizability of these findings. In addition, given nearly 50% of women of
reproductive age are overweight or obese, there is a large gap in knowledge on
how pregnancy influences cardiorespiratory fitness in this population. This is
particularly concerning considering the established cardio-metabolic health
outcomes that are associated with cardiorespiratory fitness found among nonpregnant populations(106, 168).
Given the cardio-metabolic health outcomes associated with
cardiorespiratory fitness, a few studies in the current literature assessed the
effects of exercise training in pregnancy on cardiorespiratory fitness. Perales et
al. (2016) reviewed the effects of prenatal exercise training on maternal and fetal
health and reported that of the four high-quality randomized controlled trials that
assessed cardiorespiratory fitness as an outcome, three found significant
improvements in aerobic capacity(137). While these results are encouraging, not
all exercise training studies that measured fitness were included in this review,
and controlled studies have found that exercise did not elicit improvements in
cardiorespiratory fitness(78). Although evidence suggests that cardiorespiratory
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fitness is maintained in pregnancy, decrements in cardiorespiratory fitness have
been documented among control groups in exercise training studies(47, 78, 153,
157). Interestingly, most pregnant women participating in exercise training
studies are healthy, potentially active and possess higher levels of fitness. This
might suggest that when these women participate as non-exercising controls,
they may experience some degree of detraining, which has been demonstrated
to reduce aerobic capacity(20), as a result of detraining. Additionally, the
maintenance of cardiorespiratory fitness in pregnancy may only apply to those
who continue their “usual” activities in the perinatal period.
Perales et al. (2016) concluded that the evidence regarding the positive
effect of prenatal exercise training on cardiorespiratory fitness is strong; however,
there are enough conflicting findings to suggest more research is needed. For
studies reporting null effects, factors that may have attributed to these findings
include the prescription of an insufficient exercise dose, poor compliance(117),
small sample sizes etc. Another limitation to the evidence regarding this
association is the limited number of studies that include overweight and obese
pregnant women. It is encouraging however, that the few randomized controlled
trials conducted among this population have found significant positive
effects(144, 153, 176). In addition, it would be of great interest to evaluate how
changes in cardiorespiratory fitness as a result of exercise training influence the
infant health.
Another major focus of the scientific literature with regard to
cardiorespiratory fitness in pregnancy is its effect on responses to exercise. To
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address this question, much of the literature has compared the responses to
exercise testing between “fit” and sedentary pregnant women. Pivarnik et al.
(1993) demonstrated that, in the third trimester of pregnancy, fit women had a
higher cardiovascular respiratory efficiency in response to submaximal exercise,
indicated by increased cardiac output, alveolar ventilation, and decreases in the
physiological dead space-to-tidal volume ratio relative to sedentary controls(140).
In addition, O’Neill et al. (1993), found that a given submaximal workload, trained
pregnant women had significantly lower heart rates, and marginally significant
increases in oxygen consumption, stroke volume and cardiac output relative to
untrained controls(125). Moreover, Wolfe et al. (1994), reported that at peak
exercise, aerobically conditioned pregnant women had higher power output,
oxygen uptake and heart rate compared to a non-exercising control group(185).
Two important concepts can be suggested based on the evidence regarding the
relationship between prenatal cardiorespiratory fitness and responses to
exercise. First, enhanced responses to exercise as a result of higher levels of
cardiorespiratory fitness appear to be maintained throughout pregnancy
compared to lower fit pregnant women. With regard to Pivarnik et al. (1993),
because the fit women continued to engage in physical activity throughout
pregnancy, it is difficult to discern whether the enhanced responses to exercise
would have been maintained in pregnancy had these women not participated in
exercise. As such, it cannot be concluded that the maintenance of these
responses are entirely due to higher levels of cardiorespiratory fitness in
pregnancy. However, Clapp et al. (1989) demonstrated that fit women who
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continued a moderate-to-high intensity exercise program throughout pregnancy
maintained their augmented response to exercise reflected by a similar oxygen
consumption at a given submaximal workload across all three trimesters(43).
Conversely, the enhanced responses to exercise among fit women whom
discontinued their exercise program at the beginning of pregnancy were
negatively attenuated, illustrated by increased oxygen consumption at a given
submaximal workload throughout pregnancy. These findings potentially suggest
that in order to maintain pre-pregnant cardiorespiratory fitness levels in
pregnancy, a woman may need to continue to participate in her “usual” activities.
Collectively, from this evidence it seems that cardiorespiratory fitness may
be maintained throughout pregnancy, however this may be dependent on the
change in activity level of the preconception to prenatal period. In addition, it
appears that cardiorespiratory fitness can be improved as a result of prenatal
exercise training. Because the exercise programs varied considerably among the
exercise training studies, it is difficult to determine a dose that elicits an increase
in fitness suggesting more research in this area is needed. Further, it seems that
the enhanced responses to exercise as a result of increased fitness (e.g. cardiac
output) are maintained in pregnancy; however, this may also be dependent on
maternal activity in pregnancy. Lastly, a considerable limitation of this research is
the paucity of these studies conducted among overweight and obese pregnant
women, a population that may benefit the most from increase aerobic capacity.
Prenatal Cardiorespiratory Fitness and Fetal Growth
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Given the established cardio-metabolic health outcomes associated with
higher levels of cardiorespiratory fitness (e.g. improved glycemic/lipidemic
control) it seems reasonable to speculate that increased aerobic capacity in the
perinatal period may have favorable effects on infant weight status. The
underlying mechanisms to support this hypothesis are consistent with those
suggested in the maternal resources hypothesis whereby improved glycemic and
lipidemic control may control nutrient supply to the infant and restricting growth to
within normal ranges.
While several studies have assessed cardiorespiratory fitness in
pregnancy, a small number of studies have examined its influence on infant
weight status. As such, the evidence for this relationship is limited. Wong et al.
(1987) found that infants born to fit pregnant women were, on average, heavier
(3733g vs 3680g) compared to lower-fit counterparts(186). Similarly, Errkola
(1975) reported that trained pregnant women delivered more infants weighing
greater than 3500g compared to lower-fit women suggesting a higher level of
fitness was associated with increased birthweight(59). Kardel (1998) evaluated
the effect of exercise intensity on maternal and infant outcomes among pregnant
elite athletes(84). Pregnant women participating in the higher intensity exercise
program resulted in higher levels of cardiorespiratory fitness and the delivery of
larger infants (3650g vs 3590g) compared to women in the moderate intensity
exercise program. Conversely, Clapp et al (2002) demonstrated that fit pregnant
women continuing their exercise program into late pregnancy had lighter (3390g
vs 3810g) and leaner (8.3% vs 12.1%) infants compared to less fit women whom
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decreased their exercise in mid-pregnancy(42). Both Pomerance et al. (1973),
Price et al. (2005) and Bisson (2013) found that cardiorespiratory fitness had no
association with infant birthweight(22, 141, 144).
Based on the current scientific literature it appears that the evidence
regarding the effect of maternal cardiorespiratory fitness on infant weight status
is equivocal and very limited. Several limitations may explain the present
ambiguity. First, there was considerable variability in the fitness testing protocols
such as the mode (cycle vs treadmill), equations used to estimate maximal
oxygen consumption and thresholds used to determine “fit” versus “unfit.”
Second, although evidence indicates that cardiorespiratory fitness is maintained
during pregnancy, the timing of the fitness assessments (i.e. 1st – 3rd trimester)
between studies was highly variable, potentially attenuating the magnitude of its
association with infant weight status. Third, various metrics of infant weight status
were used across the studies including birthweight, macrosomia and percent
body fat each of which provide different information on infant anthropometry.
Fourthly, most of these studies utilized small samples potentially increasing the
difficulty of detecting a difference in infant weight status. Lastly, nearly all of the
studies were conducted among normal weight samples suggesting that the
evidence of this relationship among overweight and obese pregnant women is
severely limited.
The Moderating Role of Prenatal Physical Activity and Cardiorespiratory Fitness
Given the well-documented potent effects of both physical activity and
cardiorespiratory on cardio-metabolic health, it seems reasonable to suggest that

148

active and/or fit pregnant women may demonstrate improved metabolic control
enabling better control of nutrient supply to the fetus thereby protecting the fetus
from potential overgrowth. Considerable evidence has indicated that high levels
of maternal adiposity are positively associated with the delivery of larger
infants(69). In addition, increased adiposity has also been demonstrated to be
associated with decreased metabolic health. Assuming this, it may be
hypothesized that physical activity and/or cardiorespiratory fitness may moderate
the association between maternal adiposity and infant weight status. That is,
physical activity and/or a higher level of cardiorespiratory fitness in the
preconception-prenatal period may alleviate the negative effects of maternal
adiposity on birthweight such that the fetus may be protected from overgrowth.
Currently, to our knowledge, only two studies exist in the scientific
literature that have assessed physical activity as a potential moderator on the
relationship between maternal adiposity and infant weight status. Fleten et al.
(2010) evaluated the direct and indirect associations between exercise in
pregnancy on infant birthweight and maternal adiposity in a large Norwegian birth
cohort(64). These authors found that exercise (at 17 and 30 weeks gestation)
when accounting for maternal body mass index, resulted in a minor impact on
infant birthweight. Interestingly, these authors did not explore the impact of the
change in exercise from early to late pregnancy and the potential influence on
birthweight. In addition, the authors did not describe in any amount of detail the
potential moderating effect of exercise in pregnancy on the relationship between
maternal adiposity and infant birthweight. In another study, Krogsgaard et al.
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(2013) assessed the moderating effect of pre-pregnancy physical activity on the
relationship between maternal adiposity and infant weight status in a Norwegian
cohort(99). These authors found that for overweight and obese women, those
women who reported no or low level of physical activity in the preconception
period were more likely to give birth to a heavier neonate and had increased
odds of delivering a macrosomic infant compared to women who reported
participating in physical activity in the pre-pregnancy period. According to these
authors, concluded participation in pre-pregnancy physical activity may attenuate
the association between maternal adiposity and infant weight status.
In the present scientific literature, no studies exist which assess the
potential moderating effect of cardiorespiratory fitness on the association
between maternal adiposity and infant weight status. However, assumptions
based on evidence in non-pregnant populations may be drawn to support this
relationship. Considerable evidence among non-pregnant populations has
demonstrated that higher levels of cardiorespiratory fitness are inversely
associated with several cardio-metabolic health outcomes independent of
adiposity(106). This may suggest that higher fitness may alleviate the adverse
effects of adiposity on metabolic health. Thus, among pregnant women it is
hypothesized that a higher level of cardiorespiratory in pregnancy may attenuate
the association between maternal adiposity and infant weight status. However, to
our knowledge this has not yet been assessed in the literature.
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Summary
Given the high prevalence of overweight and obesity in the pregnant
population and the robust association between maternal weight status and infant
weight status, a strategy that enables a woman to control her metabolic
intrauterine environment should be a public health priority. Considering the
potent effects of physical activity and cardiorespiratory fitness on metabolic
health, it seems reasonable to suggest that these factors influence fetal growth in
the perinatal period. However, the evidence regarding the potential moderating
effect of physical activity and/or fitness on the relationship between maternal
adiposity and infant weight status is largely unknown.
Study One
Purpose
The aim of this study is to determine if maternal physical activity in the
preconception and perinatal periods modify the association between maternal
weight status and infant weight status among a nationally representative and
diverse sample of women delivering live-birth infants. We will address the
purpose of this study with two objectives. In the first objective (Objective 1A), we
will determine if prenatal physical activity modifies the association between
maternal weight status and infant weight status. In the second objective
(Objective 1B), we will determine if pre-pregnancy physical activity alters the
moderating effect of prenatal physical activity on the relationship between
maternal weight status and infant weight status.
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Methods
Study Design & Sampling
The National Maternal Infant Health Survey (NMIHS), conducted by the
National Center for Health Statistics in 1988, employed a follow-back survey
study design. Existing data from this study will be used to address the aim of this
study. The NMIHS sampled women who had a live birth, fetal death or infant
death in 1988. In order to make inferences on the nationally representative
sample, the NMIHS used a complex survey design that drew stratified samples
from live births, fetal and infant deaths in the U.S. (except Montana and South
Dakota), identified via registered birth and death certificates. For the purposes of
this study, only women delivering live-birth infants will be included. Within livebirth sampling frame, two sampling strata were formed based on the child’s race
(Black or other than Black) and infant birthweight (<1500g, 1500-2499g, ≥2500g).
Within each of the sampling stratum, birth certificates were sorted by maternal
marital status and age prior to sampling. In this study, Black infants and very lowbirthweight (<1500g) and moderately low-birthweight infants were oversampled.
Further details on the sampling procedures are provided elsewhere(152).
Study Population & Data Collection
A total of 13,417 live-birth infants were sampled. Mothers of these infants
were mailed a 35-page questionnaire which inquired about prenatal care,
maternal health habits, delivery of the infant, hospitalizations pre- and postdelivery, previous and subsequent pregnancies, maternal and paternal
sociodemographic characteristics and the infant’s health. The recall period,
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defined as the time between the delivery of the infant and the receipt of the
maternal questionnaire, was on average 17 months (6 to 32 months). Of the
13,417 mothers who delivered a live-birth infant, 9,953 mothers responded to the
questionnaire (74.2%). The characteristics of mothers differed among those
whom responded and did not respond to the questionnaire. The questionnaire
was more likely to be completed by mothers who were between 20 to 39 years,
White, married, had fewer than four children, received early prenatal care, more
education, and resided in the Midwest region of the U.S. Additionally, mothers of
low birthweight infants (<2500g) were also less likely to respond. Because there
are maternal and fetal physiologic differences between single and multiple (e.g.,
twins) pregnancies, our analyses will be further restricted to women with
singleton pregnancies who delivered a live-birth infant (n=9089).
Outcome Variable: Infant Birthweight
Infant weight status will act as the primary outcome variable of interest
and be expressed as a continuous and categorical variable. As a continuous
outcome, infant weight status will be expressed as infant birthweight, defined as
the weight in grams at the time of delivery. As a categorical outcome, we will use
established cut-points in the scientific literature to identify large-for-gestationalage infants (≥90th percentile), average-for-gestational age (11th to 89th percentile)
and small-for-gestational age (≤10th percentile)(6). Data on infant birthweight and
gestational age were extracted from the infant birth certificate.
Exposure Variable: Maternal Pre-Pregnancy Body Mass Index
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Maternal pre-pregnancy body mass index (BMI) will act as the primary
independent variable. BMI will be calculated using the standard equation: BMI=
Weight (kg)
Height (m)2

. Maternal height was self-reported on the mother’s questionnaire in feet

and inches as follows: “How tall are you as of now?” Because height does not
change during pregnancy, her height at the time the questionnaire was
administered will serve as “maternal pre-pregnancy height.” Pre-pregnancy
weight was self-reported on the mother’s questionnaire in pounds as follows
“What was your weight just before becoming pregnant…” For ease of
interpretation, maternal pre-pregnancy BMI will be categorized into three groups
using widely accepted cut-points(1) as follows: underweight (≤18.49 kg/m2),
normal (18.50 – 24.99 kg/m2), overweight (25.00 – 29.99 kg/m2) and obese
(≥30.00 kg/m2).
Moderating Variables: Maternal Physical Activity
Maternal physical activity in the preconception and perinatal periods will
act as moderating variables. Pre-pregnancy physical activity was self-reported on
the mother’s questionnaire by the following question: “Did you exercise or play
sports at least three times a week before you got pregnant?…include brisk
walking for ½ hour or more, jogging, aerobics swimming etc.” The response was
recorded as “yes” or “no.” Prenatal physical activity will be was self-reported on
the mother’s questionnaire by the following question: ““Did you exercise or play
sports at least three times a week after you got pregnant?…include brisk walking
for ½ hour or more, jogging, aerobics swimming etc.” The response was
recorded as “yes” or “no.” Additionally, in order to quantify a dose of prenatal
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physical activity, we will use the following question: “How many months of this
pregnancy did you exercise or play sports at least 3 times per week?” The
response format was 0 to 10 months. While we acknowledge that these
questions specifically refer to ‘exercise’ in the preconception and prenatal
periods, we surmise that the information provided with regard to this behavior is
more reflective of ‘physical activity.’ As such, we will use the term ‘physical
activity’ when referring to this behavior.
Maternal Covariates
Demographics
Maternal demographic characteristics that may be considered potential
covariates include age and race/ethnicity. These data were self-reported and
extracted from the birth certificate and mother’s questionnaire, respectively.
Maternal age was reported in number of years. Race was reported in the
following groups: White, Black, Asian or Pacific Islander or Other. For ethnicity,
mothers indicated whether they were from Spanish or Hispanic origin or
ancestry. Responses were recorded as “yes” or “no.” Racial and ethnic groups
will be collapsed into the following categories: Non-Hispanic White, Non-Hispanic
Black, Hispanic and Other.
Pregnancy-Related Covariates
Maternal pregnancy-related characteristics that may be considered
potential covariates include net gestational weight gain and parity. Net
gestational weight gain will be calculated using three variables: pre-pregnancy
weight, weight just prior to delivery and infant birthweight. Weight gain variables
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were self-reported in pounds and were retrieved from the mother’s questionnaire.
Infant birthweight was extracted from the birth certificate. Gestational weight gain
will be calculated by first subtracting pre-pregnancy weight from weight just prior
to delivery to determine gestational weight gain.
Maternal Behaviors
Maternal behaviors that may be considered potential covariates include
smoking status and alcohol use. These data were self-reported and extracted
from the mother’s questionnaire. Smoking status and alcohol use were
determined by whether or not the mother smoked and/or drank in the last 12
months before delivery. Responses were recorded separately, in a “yes” or “no”
format.
Infant Covariates
Infant characteristics that may be considered potential covariates include
sex and gestational age. Data on infant sex and gestational age were extracted
from the birth certificate. Sex of the infant was recorded as male or female.
Gestational age was reported in weeks. The method used to calculate
gestational age likely varied but may have included last menstrual period or
physician’s estimate (e.g. ultrasound or Dubowitz/Ballard).
Statistical Analyses
To determine if pre-pregnancy and prenatal physical activity influence the
relationship between maternal weight status and infant weight status, multiple
linear and multinomial logistic regression analyses will be performed. The only
difference between these two analyses is the expression of the outcome variable
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(infant weight status). In the multiple linear regression analyses, infant weight
status will be expressed continuously as birthweight in grams. In the multinomial
logistic regression analyses, infant weight status will be expressed as a
categorical variable with three levels: large-for-gestational age (LGA), averagefor-gestational age (AGA) and small-for-gestational age (SGA). AGA will act as
the referent group. For both analyses, the expressions of the primary
independent, moderating and covariate variables and the model building steps
will be identical.
Study Variables
For all the analyses the following variables will be expressed categorically:
maternal body mass index (four levels: underweight, normal weight [referent],
overweight, and obese), pre-pregnancy and prenatal physical activity (two levels:
yes and no [referent]), maternal race/ethnicity (four levels: Non-Hispanic White
[referent], Non-Hispanic Black, Hispanic, and Other), smoking and alcohol status
(two levels: yes and no [referent]), and infant sex (two levels: male [referent] and
female). The following variables will be expressed continuously: physical activity
dose (number of months), maternal age (years), net gestational weight gain
(pounds), and gestational age (weeks).
Model Building
All statistical models will be built in the following stages. (1) Bivariate
associations will be assessed between all the predictor variables (i.e.
independent, moderating and covariates) and both expressions of the outcome
variable. (2) The crude association between maternal body mass index and
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infant weight status will be examined with a bivariate association and
assumptions of the statistical methods will be assessed (e.g. linearity, normality).
(3) To assess the main effect of prenatal physical activity, this variable will be
entered into the model with the maternal body mass index. (4) To determine the
unadjusted moderating effect of prenatal physical activity, an interaction term
between maternal body mass index and prenatal physical activity will be entered.
(5) Maternal and infant covariates will then be individually added to the model.
To determine if pre-pregnancy physical activity alters the impact of prenatal
physical activity on the association between maternal body mass index and infant
weight status, steps 3 through 5 will be repeated to build a new model inclusive
of this variable. That is, pre-pregnancy physical activity will first be added the
unadjusted model (from step 3) as a main effect. Then, the interaction between
prenatal physical activity and maternal BMI will be added (see step 4). To
address the moderating effect of pre-pregnancy physical activity a three-way
interaction term will be generated. However, before this, two additional two-way
interactions must also be entered into to the unadjusted model, 1) maternal BMI
and pre-pregnancy physical activity, and 2) pre-pregnancy and prenatal physical
activity. The two-way interactions will be entered individually, followed by a threeway interaction between pre-pregnancy physical activity, maternal BMI and
prenatal physical activity. Lastly, maternal and infant covariates will be added
separately.
In addition, the NMIHS employed a complex survey design in order to collect a
nationally, representative sample of registered births (and deaths) of infants born
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to mothers in the U.S. in 1988. Weights were generated to account for this study
design and allow for inferences to be made on the population level. As such,
weights will be used in all statistical analyses. All statistical analyses will be
performed in SAS, using PROC SURVEYREG and SURVEYLOGISTIC (version
9.4). An alpha level of 0.05 will be used to denote statistical significance for all
analyses. For multiple linear regression analyses, mean regression coefficients
(β) and their respective 95% confidence intervals will be estimated. For
multinomial logistic regression analyses, odds ratios and the corresponding 95%
confidence intervals will be calculated.
Study 2
Purpose
The aim of this study is to determine the effect of maternal
cardiorespiratory fitness and objectively-measured physical activity on infant
weight status in a sample of overweight and obese pregnant women. We will
address this study with three objectives. In the first objective (Objective 2A), we
will evaluate the independent association between cardiorespiratory fitness in
mid-pregnancy on infant weight status. In the second objective (Objective 2B),
we will examine the independent association between objectively-measured
physical activity in the perinatal period and infant weight status. In the third
objective (Objective 2C), we will assess the joint association of maternal
cardiorespiratory fitness and objectively-measured physical activity in the
perinatal period and infant weight status.
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Methods
Study Design
To address the aim of this study, data from a randomized comparative trial
(RCT) conducted between November 2001 and July 2006 will be used(190).
Briefly, the primary purpose of the RCT was to examine the effects of moderate
intensity exercise during pregnancy on the incidence of preeclampsia and the
pathophysiological progress of preeclampsia (e.g. oxidative stress). Secondary
outcomes of the exercise trial included maternal weight gain and birth outcomes.
Participant Eligibility & Recruitment
Pregnant women were recruited from nine prenatal clinics under two
medical care systems in Michigan. From 14 to 17 weeks of gestation, a run-in
period was conducted with weekly lab visits that consisted of a medical record
review, cardiorespiratory fitness test, survey administration and a thorough
explanation of the exercise trial.
In order to be eligible for the exercise trial pregnant women were: 1) less
than 14 weeks gestation, 2) diagnosed with preeclampsia in a previous
pregnancy, 3) had a peak oxygen consumption ≤ 50th percentile of women in
their respective age-group, 4) participated in a sedentary lifestyle or had a selfreported energy expenditure of < 840 kcals per day. Pregnant were excluded
from the exercise trial if they: 1) were diagnosed with chronic hypertension or
pre-gestational diabetes, 2) had medical or physical limitations that prevented
them from participating in exercise, 3) were instructed not to exercise during
pregnancy by a physician or 4) were unable to communicate with research staff
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due to low mental acuity or unable to speak English. A total of 210 women
agreed to participate in the study and 41% (n=86) of these women were excluded
during the run-in period.
Randomization and Intervention Groups
After the four-week run-in period (18 weeks of gestation), 124 participants
were randomly allocated to the intervention group (n= 64) or comparative group
(n=60) using a random numbers table. The intervention group consisted of a
walking exercise program. Participants in this group were instructed to walk for
40 minutes, five times per week at a moderate intensity (55-69% maximum heart
rate). In the comparative group, participants engaged in a stretching program of
equivalent frequency and duration of the exercising group, however were
instructed to not exceed a 10% increase in resting heart rate. Stretching sessions
consisted of the women following stretching movements delivered via a
videotape. All participants wore Polar S810 heart rate monitors to validate their
adherence to the exercise or stretching programs. In addition, women wore
wristwatch devices to enable them to track their heart rates during exercise or
stretching sessions to monitor their target heart rates. Target heart rates were
calculated using the Karvonen formula(85) for the desired exercise intensities.
Outcome Variable: Infant Weight Status
Infant weight status will act as the primary outcome variable of interest
and be expressed as a continuous and categorical variable. As a continuous
outcome, infant weight status will be expressed as infant birthweight, defined as
the weight in grams at the time of delivery. As a categorical outcome, we will use
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established cut-points in the scientific literature to identify large-for-gestationalage infants (≥90th percentile), average-for-gestational age (11th to 89th percentile)
and small-for-gestational age (≤10th percentile)(7). Data on infant birthweight and
gestational age were extracted from medical records.
Exposure Variables: Cardiorespiratory Fitness and Physical Activity
Cardiorespiratory Fitness
Cardiorespiratory fitness (CRF) will act as a primary exposure variable
and be expressed as a continuous variable. CRF was defined as peak oxygen
consumption (V̇O2peak) which was estimated via a submaximal treadmill test. CRF
was assessed twice, at 17 and 28 weeks of gestation. The exercise testing
followed the Cornell Exercise Protocol(129). This protocol consisted of walking
on a treadmill through eight, two-minute stages with progressive increments in
speed and grade. Prior to the initiation and throughout the exercise test, heart
rate, blood pressure, fatigue, oxygen consumption, carbon dioxide production
and minute ventilation were continuously monitored. The metabolic and
respiratory markers were assessed using a portable indirect calorimeter
(VO2000, Medical Graphics Corporation, Minneapolis, MN), which has been
previously validated in a sample of sedentary pregnant women(191). Heart rate
was measured using a Polar S810 heart rate monitor (Warminster, PA) and
blood pressure was assessed using a standard sphygmomanometer. Fatigue
was measured using the Borg’s Scale of Rating of Perceived Exertion(126).
The exercise test was terminated if one of the following criteria is achieved: 1) an
RPE of 13 to 14, 2) the participant’s heart rate fell between values that

162

correspond to their 85% target heart rate and 85% age-predicted max heart rate,
3) participant request to terminate, or 4) diastolic blood pressure increases more
than 10 mmHg. V̇O2peak was determined by the highest amount of oxygen
consumed during the exercise test. V̇O2peak was expressed relative to
participants’ body weight as milliliters of oxygen per kilogram per minute (mL
O2∙kg-1∙min-1).
Physical Activity
Physical activity will be the primary exposure variable and be expressed
as a continuous variable. Daily physical activity was measured using a
pedometer (Digiwalker SW200) worn on the participants’ waist. The participants
were instructed to wear the pedometer during waking hours and to remove them
during sleep and any water-based activities (e.g., showering, swimming).
Additionally, the participants were asked to keep a log of their total daily step
counts. The pedometers were distributed to the participants at 18 weeks of
gestation and were retrieved at the end of pregnancy (prior to delivery). For the
purposes of this study, total daily steps counts will be averaged across all the
available days for each participant to provide an estimate of average daily
physical activity.
Covariate Variables: Maternal and Infant Characteristics
Maternal and infant characteristics that may be considered potential
covariates include: maternal body mass index (BMI), maternal age, gestational
weight gain (GWG), gestational age and group allocation. Maternal BMI will be
calculated using the standard equation: BMI=
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Weight (kg)
Height (m)2

. Due to the considerable

missing data for the self-reporting of pre-pregnancy weight (39%), both maternal
height and weight at 17 weeks of gestation will be used to calculate BMI. Height
and weight were objectively measured during a research lab visit using a
standard stadiometer and balance beam scale, respectively. Maternal age and
gestational age were extracted from the participants’ medical records. Because
the exposure of this intervention trial was exercise, which may influence some of
the primary independent variables and the outcome variable, we will control for
group allocation.
In the scientific literature, GWG is often calculated using self-reported prepregnancy weight and weight recorded just prior to delivery. Although both of
these variables are available, a significant proportion of these data are missing,
39% and 38%, respectively. As such, GWG will be calculated using three
alternative weight variables: weight measured at 17 and 28 weeks gestation and
infant birthweight as follows [((weight28weeks – weight17weeks) + birthweight)]. In the
3rd trimester of pregnancy, fetal growth continues to accelerate and a large
proportion of the weight gained is attributable to the weight of the fetus. Because
the weight gained during weeks 17 and 28 only capture the beginning of third
trimester (weeks 26 to 40), we will add infant birthweight (in pounds) to the
weight gained between weeks 17 and 28 as a surrogate measure for maternal
gestational weight gain. We recognize that weight may be gained in the first
trimester, however only minimal amounts have been documented and
consequently we may underestimate GWG.
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To determine whether our calculation would be an appropriate representation of
maternal weight gain, we compared it to another GWG method which utilized the
limited data available on weight just prior to delivery [(weight delivery – weight17
weeks)].

We calculated the difference between these two measures as follows:

((weight28weeks – weight17weeks + birthweight) – (weight delivery – weight17 weeks)). We
then computed the average of these differences, in pounds. The average
difference between these measures was -2.62 lbs. That is, our measure of GWG,
underestimated weight gain, on average, by 2.62 lbs. Based on what appears to
be a minimal difference between these two measures, we will use the alternative
measure of GWG in order to maximize all available data.
Statistical Analysis
To determine the effect of maternal cardiorespiratory fitness and prenatal
physical activity on infant weight status, multiple linear and multinomial logistic
regression analyses will be performed. The only difference between these two
analyses is the expression of the outcome variable (infant weight status). In the
multiple linear regression analyses, infant weight status will be expressed
continuously as birthweight in grams. In the multinomial logistic regression
analyses, infant weight status will be expressed as a categorical variable with
three levels: large-for-gestational age (LGA), average-for-gestational age (AGA)
and small-for-gestational age (SGA). AGA will act as the referent group. For both
analyses, the expressions of the primary independent and covariate variables
and the model building steps will be identical.
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Study Variables
For all the analyses the following variables will be expressed continuously:
cardiorespiratory fitness (ml O2/kg/min), prenatal physical activity (steps per
week), maternal body mass index (kg/m2), maternal age (years), gestational
weight gain (pounds), and gestational age (weeks). Group allocation (two levels:
intervention and control) will be expressed as a categorical variable.
Model Building
All statistical models will be built in the following stages. (1) Bivariate
associations will be assessed between all the predictor variables (i.e.
independent and covariates) and the both expressions of the outcome variable.
(2) To assess the independent effects of the primary independent variables (i.e.
cardiorespiratory fitness and physical activity) on infant weight status, will be
assessed with a bivariate analysis in separate models. (3) Maternal and infant
covariates will then be individually added to each model.
To determine the joint effect of cardiorespiratory fitness and physical
activity, we will create an interaction term between cardiorespiratory fitness and
physical activity. Prior to examining the interaction between cardiorespiratory
fitness and physical activity, we will include cardiorespiratory fitness as a main
effect in the unadjusted model (from step 2). After this, we enter the interaction.
Maternal and infant covariates will then be added individually to each model. This
analysis will be carried out separately with both expressions of infant weight
status. Given that participants in this sample have a cardiorespiratory fitness
level ≤50th percentile of their respective age-group, we will retain
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cardiorespiratory fitness as a continuous variable to avoid further reducing the
variability in this variable. If the interaction term is significant, we will then assess
the effect of physical activity on infant weight status on varying levels of
cardiorespiratory fitness by generating estimate statements. Because there are
no established standards for cardiorespiratory fitness in pregnant women, we will
select fitness levels for the estimate statements that correspond to values at the
25th, 50th and 75th percentiles. We will use these values and compare the
differences in the slopes for the effect of physical activity on infant weight status
between the selected cardiorespiratory fitness levels. For all analyses statistical
significance will be determined at an alpha level of 0.05. For multiple linear
regression analyses, mean regression coefficients (β) and their respective 95%
confidence intervals will be estimated. For multinomial logistic regression
analyses, odds ratios and the corresponding 95% confidence intervals will be
calculated.
Study 3
Purpose
The aim of this study is to determine the effect of change in prenatal
physical activity and cardiorespiratory fitness on infant weight status in a sample
of overweight and obese pregnant women. We will address this study with two
objectives. In the first objective (Objective 3A), we will evaluate the association
between the change in prenatal physical activity and infant weight status. In the
second objective (Objective 3B), we will examine the potential moderating effect
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of cardiorespiratory fitness on the association between prenatal physical activity
and infant weight status.
Methods
Study Design
To address the aim of this study, the same data from the randomized
comparative trial (RCT) in Study Two will be used. Briefly, the primary purpose of
the RCT was to examine the effects of moderate intensity exercise during
pregnancy on the incidence of preeclampsia (PE) and the pathophysiological
progress of preeclampsia (e.g. oxidative stress). Secondary outcomes of the
exercise trial included maternal weight gain and birth outcomes(190).
Participant Eligibility & Recruitment
Pregnant women were recruited from nine prenatal clinics under two
medical care systems in Michigan. From 14 to 17 weeks of gestation, a run-in
period was conducted with weekly lab visits that consisted of a medical record
review, cardiorespiratory fitness test, survey administration and a thorough
explanation of the exercise trial.
In order to be eligible for the exercise trial pregnant women were: 1) less
than 14 weeks gestation, 2) diagnosed with PE in a previous pregnancy, 3) had a
peak oxygen consumption ≤ 50th percentile of women in their respective agegroup, 4) participated in a sedentary lifestyle or had a self-reported energy
expenditure of < 840 kcals per day. Participant exclusion criteria are detailed in
Study Two. A total of 210 women agreed to participate in the study and 41% of
these women were excluded during the run-in period.
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Randomization and Intervention Groups
After the four-week run-in period (18 weeks of gestation), 124 participants were
randomly allocated to the exercise intervention group (n= 64) or comparative
[stretching] group (n=60) using a random numbers table. Further details on the
exercise and comparative groups are provided in Study Two.
Outcome Variable: Infant Weight Status
Infant weight status will act as the primary outcome variable of interest
and be expressed as a continuous and categorical variable. As a continuous
outcome, infant weight status will be expressed as infant birthweight, defined as
the weight in grams at the time of delivery. As a categorical outcome, we will use
established cut-points in the scientific literature to identify large-for-gestationalage infants (≥90th percentile), average-for-gestational age (11th to 89th percentile)
and small-for-gestational age (≤10th percentile)(7). Data on infant birthweight and
gestational age were extracted from medical records.
Exposure Variable: Physical Activity
Physical activity will also act as a primary exposure variable and be
expressed as continuously. Daily physical activity was measured objectively
using a pedometer (Digiwalker SW200) worn on the participants’ waist. The
participants were instructed to wear the pedometer during waking hours and
were to be removed during sleep and any water-based activities (e.g., showering,
swimming). Additionally, the participants were asked to keep a log of their total
daily step counts. The pedometers were distributed to the participants at 18
weeks of gestation and were retrieved at the end of pregnancy (prior to delivery).

169

For the purposes of this study, an average change score in physical activity will
be calculated (for details see Statistical Analysis section).
Moderating Variable: Cardiorespiratory Fitness
Cardiorespiratory Fitness
Cardiorespiratory fitness (CRF) will act as a moderating variable and be
expressed as a continuous variable. CRF was defined as peak oxygen
consumption (V̇O2peak) which was estimated via a submaximal treadmill test. CRF
was assessed twice, at 17 and 28 weeks of gestation. V̇O2peak was expressed
relative to participants’ body weight as milliliters of oxygen per kilogram per
minute (mL O2∙kg-1∙min-1). Given that CRF has been demonstrated to remain
constant throughout pregnancy, we will average the CRF values at 17 and 28
weeks gestation to represent the ‘average prenatal CRF level.’ For further
methodological details on the CRF testing, please refer to the Methods section in
Study Two.
Covariate Variables: Maternal and Infant Characteristics
Maternal and infant characteristics that may be considered potential
covariates include: maternal body mass index (BMI), maternal age, gestational
weight gain (GWG), gestational age, group allocation and baseline physical
activity. Maternal BMI will be calculated using the standard equation: BMI=
Weight (kg)
Height (m)2

. Due to the considerable missing data for the self-reporting of pre-

pregnancy weight (39%), both maternal height and weight at 17 weeks of
gestation will be used to calculate BMI. Height and weight were objectively
measured during a research lab visit using a standard stadiometer and balance
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beam scale, respectively. Maternal age and gestational age were extracted from
the participants’ medical records. Because the exposure of this intervention trial
was exercise, which may influence some of the primary independent variables
and the outcome variable, we will control for group allocation.
In the scientific literature, GWG is often calculated using self-reported prepregnancy weight and weight recorded just prior to delivery. Although both of
these variables are available, a significant proportion of these data are missing,
39% and 38%, respectively. As such, GWG will be calculated using three
alternative weight variables: weight measured at 17 and 28 weeks gestation and
infant birthweight as follows [((weight28weeks – weight17weeks) + birthweight)]. For
further details on the calculation of this variable, please see the Methods section
in Study Two.
Statistical Analysis
To determine the effect of maternal cardiorespiratory fitness and change
in prenatal physical activity on infant weight status, multiple linear and
multinomial logistic regression analyses will be performed. The only difference
between these two analyses is the expression of the outcome variable (infant
weight status). In the multiple linear regression analyses, infant weight status will
be expressed continuously as birthweight in grams. In the multinomial logistic
regression analyses, infant weight status will be expressed as a categorical
variable with three levels: large-for-gestational age (LGA), average-forgestational age (AGA) and small-for-gestational age (SGA). AGA will act as the
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referent group. For both analyses, the expressions of the primary independent
and covariate variables and the model building steps will be identical.
Change in Prenatal Physical Activity
To best represent the change in the observed patterns of physical activity
behavior, we will calculate a change score that maximizes the available data.
Prenatal physical activity was measured daily via pedometry from week 18 of
gestation until delivery, and is expressed as step counts. We will calculate the
change in step counts through a series of stages. First, we will collapse daily step
counts into average weekly steps counts for each individual. Second, we will then
calculate a baseline level of physical activity by averaging weekly step counts for
the first four weeks of measurement (i.e. 18 to 22 weeks). Using a four-week
measurement period may provide some advantages including accounting for
changes in behavior due to reaction to the device and providing a more accurate
representation of physical activity behavior. Also, during this four-week period,
gestational weight gain has not yet accelerated, which may influence levels of
physical activity and thus, minimal changes in physical activity patterns will likely
have occurred. Third, we will create five, four-week periods (22 to 26 weeks, 26
to 30 weeks, 30 to 34 weeks, 34 to 38 weeks, and 38 to 42 weeks) and for each
we will compute the average weekly step counts. Fourth, we will then determine
the average change (or difference) in step counts between each of these five
periods and baseline physical activity levels. Based on previous scientific
literature, we will assume that the change in physical activity may differ between
trimesters, with the largest declines occurring in the third trimester. As such, we
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will initially create two “physical activity change variables,” one for the second
trimester (weeks 22 to 26) and another for the third trimester (weeks 26 to 42).
In addition, it is possible that within the third trimester, the changes in the
average weekly steps across the remaining four periods may differ considerably.
As a result, we will examine the four periods of the third trimester to determine if
large differences in the changes in average weekly step counts are present. A
10% difference between the monthly periods will be considered a “large”
difference. If no large differences are present, then all four periods will be
collapsed and an average weekly step count for the entire third trimester will be
calculated. In the case where large differences exist, then an additional physical
activity change variable in the third trimester may be created.
Study Variables
For all the analyses the following variables will be expressed continuously:
changes in prenatal physical activity in the second trimester and third trimester
(steps per week), baseline physical activity (steps per week), cardiorespiratory
fitness (ml O2/kg/min), maternal body mass index (kg/m2), maternal age (years),
gestational weight gain (pounds), and gestational age (weeks). Group allocation
(two levels: intervention and control) will be expressed as a categorical variable.
Model Building
All statistical models will be built in the following stages and performed
separately with each expression of infant weight status. (1) Bivariate associations
will be assessed between all the predictor variables (i.e. independent, moderator
and covariates). (2) Because there will be more than one variable that represents
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change in physical activity (i.e. 2nd and 3rd trimesters), each variable will be
entered individually into the model, beginning with the change in the 2nd
trimester. This will assess the unadjusted effect s of changes in prenatal physical
activity on infant weight status. (3) Maternal and infant covariates will then be
individually added to each model.
Next, to determine the moderating effect of cardiorespiratory fitness on the
relationship between changes in prenatal physical activity on infant weight status,
we will create an interaction term between cardiorespiratory fitness and each
change in physical activity variable. Prior to examining the interaction, we will
thoroughly assess the relationships between these variables in the subsequent
stages. (1) We will first examine the unadjusted main effects of cardiorespiratory
fitness and change in physical activity in the 2nd trimester on infant weight status.
(2) We will assess the unadjusted main effects of cardiorespiratory fitness and
change in physical activity in the 3rd trimester on infant weight status. (3) We will
then examine the unadjusted main effects of cardiorespiratory fitness and the
changes in physical activity in the 2nd and 3rd trimesters, added sequentially. (4)
Using the model from step 3, we will enter an interaction term between
cardiorespiratory fitness and change in physical activity in the 2nd trimester. (5)
Using the model from step 4, we will add another interaction term between
cardiorespiratory fitness and change in physical activity in the 3rd trimester. (6)
Maternal and infant covariates will then be added individually to each model.
Given that participants in this sample have a cardiorespiratory fitness level ≤50th
percentile of their respective age-group, we will retain cardiorespiratory fitness as
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a continuous variable to avoid further reducing the variability in this variable. If
the interaction term is significant, we will then assess the effect of physical
activity on infant weight status on varying levels of cardiorespiratory fitness by
generating estimate statements. Because there are no established standards for
cardiorespiratory fitness in pregnant women, we will select fitness levels for the
estimate statements that correspond to values at the 25th, 50th and 75th
percentiles. We will use these values and compare the differences in the slopes
for the effect of changes in physical activity in the 2nd and 3rd trimesters on infant
weight status between the selected cardiorespiratory fitness levels. For all
analyses, statistical significance will be determined at an alpha level of 0.05. For
multiple linear regression analyses, mean regression coefficients (β) and their
respective 95% confidence intervals will be estimated. For multinomial logistic
regression analyses, odds ratios and the corresponding 95% confidence intervals
will be calculated.
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